Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Edward John Holland, MD
Document related concepts
no text concepts found
Transcript
Edward John Holland, MD Curriculum Vitae Cincinnati Eye Institute – Blue Ash 1945 CEI Drive Blue Ash, Ohio 45242 (P) 513-984-5133 Cincinnati Eye Institute - Edgewood 580 South Loop Road, Suite 200 Edgewood, KY 41017 (P) 859-331-9000 (F) 513-569-3827 Personal Information Date of Birth June 23, 1956 Place of Birth Chicago, Illinois Certification Diplomat, National Board of Medical Examiners, 1982 Diplomat, American Board of Ophthalmology, 1986 License To Practice Medicine and Surgery State of Ohio: November 5, 1999, #35077410 State of Kentucky: November 21, 1999, #35605 State of Minnesota: January 1, 1987, #031291 Education College Drake University, 1975 – 1978, B.A. St. Olaf College, 1974 - 1975 Medical School Loyola – Stritch School of Medicine, Chicago, IL 1978 – 1981, M.D. Post Graduate Training Internship Flexible, Henry Ford Hospital, Detroit, Michigan, 1981-1982 Residency Ophthalmology, University of Minnesota, 1982 - 1985 Fellowship Cornea and External Disease, University of Iowa, 1985 – 1986 Ocular Immunology, National Eye Institute, National Institutes of Health, 1986 – 1987 Appointments 2000 – Present 2000 – Present 1996 - 2000 1994 - 2000 1988 - 2000 1988 – 2000 1987 – 1999 1992 – 1996 1988 – 1993 1987 – 1992 Professor of Ophthalmology, University of Cincinnati Director, Cornea and External Disease Services, Cincinnati Eye Institute, Cincinnati, Ohio Professor, Department of Ophthalmology, University of Minnesota Elias Potter Lyon Chair in Ophthalmology Director, Cornea and External Disease Fellowship, Department of Ophthalmology, University of Minnesota Director, Cornea and External Disease Service, Department of Ophthalmology, University of Minnesota Consultant, Cornea and External Disease, Hennepin County Medical Center, Minneapolis, Minnesota Associate Professor, Department of Ophthalmology, University of Minnesota Consultant, Cornea and External Disease, Veterans Administration Hospital, Minneapolis, Minnesota Assistant Professor, Department of Ophthalmology, University of Minnesota Awards and Honors - - Castroviejo Award, The Cornea Society, 2013 American Academy of Ophthalmology's Life Achievement Honor Award, 2012 Binkhorst Medal, American Society of Cataract and Refractive Surgery, 2008 Estelle Doheny Living Tribute Award – USC “The Vision Award,” 2006 American Academy of Ophthalmology Senior Achievement Award, 2002 Eye Bank Association of America Paton Society Award, 2002 American Academy of Ophthalmology Honor Award, 1993 Best Teaching Faculty Award, Department of Ophthalmology, University of Minnesota, 1988, 1993 Heed Ophthalmic Foundation Fellowship, 1985 – 1986 Minnesota Society for the Prevention of Blindness and Preservation of Hearing, 1984 Fae M. Shawhan Award, Drake University Outstanding Premedical Student of the Class of 1978 Magna Cum Laude, Drake University, 1978 Leadership Positions in Major Ophthalmic Organizations American Academy of Ophthalmology 2005 – 2010 Board of Trustees 2005 – 2010 Secretary of Annual Meeting 1995 – 2010 Associate Secretary of Annual Meeting American Society of Cataract and Refractive Surgery 2012 – Present Program Chair 2008 – Present Board of Directors 2011 – 2012 2010 – 2011 2009 – 2010 2008 – 2009 2001 – 2008 President President – Elect, Executive Committee Treasurer, Executive Committee Secretary, Executive Committee Chair, Cornea Clinical Committee The Cornea Society 2008 – 2012 1993 – 2006 2004 – 2005 2001 – 2003 1996 – 2000 Board of Directors Board of Directors Co – Director, World Cornea Congress V President Executive Secretary-treasurer Eye Bank Association of America 1990 – 2010 Board of Directors 2006 – 2008 Chair, Eye Bank Association of America 1996 – 2004 Chair, Medical Advisory Board Minnesota Academy of Ophthalmology 1997 – 1998 President 1996 – 1997 Vice President Administrative Experience 2013 – Present 1988 – Present 2011 – 2012 2011 – 2012 2008 – 2012 2005 – 2011 1993 – 2011 2009 – 2010 2009 – 2010 2009 – 2010 2009 – 2010 2005 – 2010 2005 – 2010 1998 – 2010 1996 – 2010 1990 – 2010 2008 – 2009 2006 – 2008 Program Chair, American Society of Cataract and Refractive Surgery Minnesota Lions Eye Bank: Associate Medical Director President, Executive Committee, America Society of Cataract and Refractive Surgery President American Society of Cataract and Refractive Surgery Chair, International Meetings Committee, American Academy of Ophthalmology Secretariat of Annual Meeting, American Academy of Ophthalmology The Cornea Society, Board of Directors Subspecialty Day Committee – Member, American Academy of Ophthalmology Awards Committee – Member, American Academy of Ophthalmology Nominating Committee – Member, American Academy of Ophthalmology Treasurer, Executive Committee, American Society of Cataract and Refractive Surgery Committee of Secretaries – Member, American Academy of Ophthalmology Board of Trustees, American Academy of Ophthalmology American Board of Ophthalmology, Fellowship Accreditation Committee: Subspecialty Standards Committee Eye Bank Association of America: Executive Committee Eye Bank Association of America: Medical Advisory Board Secretary, Executive Committee, American Society of Cataract and Refractive Surgery Chair, Eye Bank Association of America 2001 – 2008 1996 – 2006 2004 – 2005 1999 – 2004 1995 – 2004 2000 – 2003 1998 – 2002 1992 – 2002 1992 – 2002 1996 – 2000 1993 – 2000 1989 – 2000 1993 – 1999 1997 – 1998 1996 – 1998 1996 – 1998 1996 – 1998 1995 – 1998 1996 – 1997 1996 – 1997 1993 – 1997 1994 – 1996 1994 – 1996 1989 – 1995 1993 – 1994 1993 – 1994 1990 – 1992 1990 – 1991 1989 – 1990 Chair, Cornea Clinical Committee, American Society of Cataract and Refractive Surgery Eye Bank Association of America: Chairman, Medical Advisory Board Co-Director, World Cornea Congress V International Ocular Surface Society: Vice President American Academy of Ophthalmology: Chairman, Skills Transfer Committee The Cornea Society: President Eye Bank Association of America: Scientific Program Committee Eye Bank Association of America: Accreditation Committee Eye Bank Association of America: Research Committee Castroviejo Cornea Society: Executive Secretary-Treasurer American Academy of Ophthalmology: Alternate Counselor Minnesota Academy of Ophthalmology: Board of Directors American Academy of Ophthalmology: Committee on Eye Banks Minnesota Academy of Ophthalmology: President Eye Bank Association of America: Accreditation Committee Eye Bank Association of America: Chairman, Medical Advisory Board Committee Eye Bank Association of America: Scientific Program & Meetings Committee American Academy of Ophthalmology: Cornea Panel of the Committee on Ophthalmic Procedures Assessment Minnesota Academy of Ophthalmology: Chairman, Internal Affairs Committee Minnesota Academy of Ophthalmology: Vice President Minnesota Academy of Ophthalmology: Chairman, Membership Committee Eye Bank Association of America: Exam Committee Eye Bank Association of America: Research Committee American Academy of Ophthalmology: Regional Update Committee Eye Bank Association of America: Vice-Chairman, Medical Advisory Board Eye Bank Association of America: Chairman, Medical Advisory Board Eye Bank Association of America: Scientific Program Committee: Chairman Minneapolis Ophthalmological Society, Minneapolis, MN: President Minneapolis Ophthalmological Society, Minneapolis, MN: SecretaryTreasurer Fellowship Trainees 2013 – 2014 2012 – 2013 2011 – 2012 2010 – 2011 2009 – 2010 2008 – 2009 2007 – 2008 2006 – 2007 2005 – 2006 2004 – 2005 2003 – 2004 2002 – 2003 2001 – 2002 2000 – 2001 1999 – 2000 1998 – 1999 1997 – 1998 1996 – 1997 1995 – 1996 1994 – 1995 1993 – 1994 1992 – 1993 1991 – 1992 1990 – 1991 1989 – 1990 1988 – 1989 1987 – 1989 1987 – 1988 Kevin J. Shah, M.D. Mahshad Darvish-Zargar, M.D. Andrea Y. Ang, M.D. Clara C. Chan, M.D. Joseph M. Biber, M.D. Kristiana D. Neff, M.D. David B. Hair, M.D. Heather M. Skeens, M.D. Manan I. Shah, M.D. Julie H. Tsai, M.D. John M. Freeman, M.D. Harilaos S. Brilakis, M.D. Joung Y. Kim, M.D. Michael L. Nordlund, M.D., PhD. Asim R. Piracha, M.D. Monika A. Malecha, M.D. Douglas G. Katz, M.D. Mark Miller, M.D. Joseph P. Leong-Sit, M.D. Suresh Mandava, M.D. Thomas P. Cowden, M.D. Christopher R. Croasdale, M.D. Reza M. Moyzayeni, M.D. Daryl R. Pfister, M.D. Louis E. Prost, M.D. Bradley H. Scharf, M.D. Andrew L. Moyes, M.D. Florentino R. Palmon, M.D. David R. Hardten, M.D. Audrey R. Talley, M.D. Michael R. Grimmett, M.D. David G. O’Day, M.D. Mark H. Barak, M.D. Richard A. Bowers, M.D. Todd W. Gothard, M.D. Frank A. Bucci, M.D. Anthony J. Lubniewski, M.D. Richard J. Duffey, M.D. Ralph W. Zabel, M.D. Peter J. Agapitos, M.D. Eric F. Pearlstein, M.D. Cathryn L. Welch, M.D. Grants (25) 1. Jaeb Center for Health Research: Corneal Donor Study; Evaluation of the Efficacy of Older Corneal Donor Tissue, Co-Principal Investigator, ($1,800,000) 1999 - Present. 2. Storz Ophthalmic Pharmaceuticals: "A Phase II, Randomized, Single-Masked (Investigator), Active Controlled, Parallel Evaluation of the Safety and Efficacy of Cidofovir Topical Ophthalmic Solution in the Treatment of Herpes Epithelial Keratitis," Principal Investigator, ($21,640). 1996. 3. Senju Pharmaceuticals: "A Double-Masked, Randomized Study to Compare the Efficacy and Safety of CT-112 Ophthalmic Suspension versus Placebo for Diabetic Corneal Epithelioplasty," Principal Investigator, ($11,333). 1995. 4. Storz Ophthalmic Pharmaceuticals: "A Phase II, Randomized, Double-Masked, PlaceboControlled, Safety and Efficacy Study of Cidofovir Topical Ophthalmic Solution in the Treatment of Viral Epidemic Keratoconjunctivitis (EKC)," Principal Investigator, ($16,230). 1996 - 1997. 5. Eye Bank Association of America, Inc.: "Confocal Microscopy in Early Cornea Transplant Rejection," Principal Investigator, ($7,940). 1995. 6. Minnesota Medical Foundation: Pre Clinical Studies of Gene Therapy for Scheie Keratopathy, CoInvestigator, ($8,000). 1995. 7. Smith-Kline Beecham Pharmaceuticals: "Treatment of Ophthalmic Zoster with Famciclovir or Acyclovir," Principal Investigator, ($32,240). 1995 - 1997. 8. NIH/Emory University: "Prospective Evaluation of Radial Keratotomy," Co-Investigator, ($48,406). 1992 - 1994. 9. Tissue Banks International: "Efficacy of Topical Lyposome Encapsulated Rapamycin in the Rat Orthotropic Transplant Model," Principal Investigator, ($10,000). 1994 - 1995. 10. National Eye Institute, Minnesota Center, U10-EY03761-13: "Prospective Evaluation of Radial Keratotomy," Co-investigator, 1980-1994. 11. Tissue Banks International: Efficacy of Topical Lyposome Encapsulated Rapamycin in the Rat Orthotropic Penetrating Keratoplasty Model, Principal Investigator, ($9,500). 1994. 12. Storz Ophthalmics, Inc.: Evaluation of the Efficacy of New Topical Agents to Inhibit Corneal Neovascularization, Principal Investigator, ($73,334). 1994 - 1995. 13. Eye Bank Association of America Research Grant Urocanic Acid in Prevention of Corneal Rejection in the Rat Penetrating Keratoplasty Model, Principal Investigator, ($5000). 1993. 14. Glycomed/Galardin MPI Study, Principal Investigator, ($23,500). 1993. 15. Wyeth-Ayerst: Evaluation of Rapamicin in Corneal Graft Rejection, Principal Investigator, ($18,500). 1992. 16. Bristol-Myers Squibb Company: Suppression of Corneal Graft Rejection using 15-Deoxyspergualin, Principal Investigator, ($18,500). 1992. 17. Storz Ophthalmics, Inc.: Effect of Topical Tetracycline on Corneal Neovascularization, Principal Investigator, ($7,500). 1992. 18. Storz Ophthalmics, Inc.: Effect of PDGF on Corneal Wound Healing, Principal Investigator, ($7,500). 1992. 19. Sandoz Pharmaceutical Corporation: Multicentered Clinical Trial of Sandiummune 2% Ointment in the Treatment of Keratoconjunctivitis Sicca, Principal Investigator, ($28,800). 1991. 20. Bristol-Myers Squibb Company: Suppression of Corneal Graft Rejection using 15-Deoxyspergualin, Principal Investigator, ($7,500). 1991. 21. Minnesota Medical Foundation: Corneal Transplant Rejection Studies Using Endothelial Cell Seeding and Immunochemical Techniques, Principal Investigator, ($6,000). 1990. 22. Eye Bank Association of America Research Grant: Whole Globe Enucleation vs. In-situ Corneal Excision. A Comparison of Tissue Contamination and Trauma, Principal Investigator, ($5,000). 1990. 23. Sandoz Pharmaceuticals Corporation: Multicenter Clinical Trial of Sandimmune 2% Ointment in the Prevention of Corneal Graft Rejection in High Risk Corneal Transplant Patients, Principal Investigator, ($120,000). 1989. 24. Institut Merieux Corporation: Evaluation of New Immunosuppressive Agents in the Prevention of Corneal Graft Rejection, Co-Investigator, ($18,000). 1989. 25. Eye Bank Association of America Research Grant: The Antigenic Modification of Corneal Tissue and its Effect on Corneal Graft Survival in the Rat Transplantation Model, Principal Investigator, ($5,000). 1989. Professional Societies - American Academy of Ophthalmology American Board of Ophthalmology, Diplomat American Medical Association American Ophthalmological Society American Society of Cataract and Refractive Surgery Association for Research in Vision and Ophthalmology Cincinnati Society of Ophthalmology Eye Bank Association of America Hennepin County Medical Society International Intra-Ocular Implant Club International Ocular Surface Society Iowa Eye Association Midwest Cornea Association - Minneapolis Ophthalmological Society Minnesota Academy of Ophthalmology and Otolaryngology Minnesota State Medical Society Ocular Microbiology and Immunology Group Paton Society The Cornea Society The Society of Heed Fellows Medical School and Hospital Activities 1993 – 2000 1989 – 2000 1987 – 2000 1995 – 1997 1994 – 1996 1992 – 1994 1989 – 1991 1986 – 1987 1986 – 1987 Scientific Reviewer 2000 – Present 1995 – Present 1994 – Present 1992 – Present 1991 – Present 1990 – 1995 University of Minnesota Hospital and Clinic: Operating Room Committee University of Minnesota Medical School: Interviewer University of Minnesota Medical School: Medical Student Advisor University of Minnesota Hospital and Clinic (FORT): Faculty Organization and Relationship Task Force University of Minnesota: Ambulatory Surgery Center Committee University of Minnesota Hospital: Strategic Planning Task Force Committee Ophthalmology Course for Second Year Medical Students, University of Minnesota Medical School: Director National Institutes of Health: Quality Assurance Committee National Institutes of Health: Laser Committee New England Journal of Medicine Journal of Cataract and Refractive Surgery Archives of Ophthalmology Ophthalmology Investigative Ophthalmology and Visual Science Cornea Current Eye Research American Journal of Ophthalmology Cornea Journal Editorial Board 2010 – Present Korean Journal of Ophthalmology; Editorial Board 2009 – 2013 EyeWorld; Medical Editor 2005 – 2013 Cornea: Editorial Board; Associate Editor 2002 – 2004 The Ocular Surface; Associate Editor Post Graduate Courses (55) 1. American Society of Cataract and Refractive Surgery Winter Update Course, Co – Course Director. Aventura, FL. 2013. 2. American Society of Cataract and Refractive Surgery Winter Update Course, Co – Course Director. Playa del Carmen, Mexico. 2012. 3. American Society of Cataract and Refractive Surgery Winter Update Course, Co – Course Director. West Palm Beach, FL. 2011. 4. American Society of Cataract and Refractive Surgery Winter Update Course, Co – Course Director. Playa del Carmen, Mexico. 2010. 5. American Society of Cataract and Refractive Surgery Winter Update Course, Co – Course Director. Playa del Carmen, Mexico. 2009. 6. American Society of Cataract and Refractive Surgery, Limbal Stem Cell Transplantation Course, Course Co-Director. San Diego, California, 2004. 7. American Society of Cataract and Refractive Surgery, Penetrating Keratoplasty Course, Course Co-Director. San Diego, California, 2004. 8. American Society of Cataract and Refractive Surgery, AlphaCor Course, Instructor. San Diego, California, 2004. 9. American Academy of Ophthalmology, Advanced Keratoplasty Techniques Didactic Session, Course Director. Annaheim, California, 2003. 10. American Academy of Ophthalmology, Advanced Keratoplasty Techniques Laboratory course, Course Director. Anaheim, California, 2003. 11. American Academy of Ophthalmology, Advanced Keratoplasty Techniques Didactic Session. Course Director. Orlando, Florida, 2002. 12. American Academy of Ophthalmology, Advanced Keratoplasty Techniques Laboratory course, Course Director. Orlando, Florida, 2002. 13. American Academy of Ophthalmology, Current Concepts and New Techniques in Corneal Transplantation course, Instructor. Orlando, Florida, 1999. 14. American Academy of Ophthalmology, Advanced Phacoemulsification Course, Instructor. Orlando, Florida, 1999. 15. American Academy of Ophthalmology, Current Concepts and New Techniques in Corneal Transplantation course, Instructor. Orlando, Florida, 1999. 16. American Academy of Ophthalmology, Advanced Phacoemulsification Course, Instructor. Orlando, Florida, 1999. 17. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. New Orleans, Los Angeles, 1998. 18. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. New Orleans, Los Angeles, 1998. 19. American Academy of Ophthalmology, Advanced Phacoemulsification, Cornea and Glaucoma Surgery Course. AAO Special Focus Course, Palm Springs California, Course Director. 1998. 20. American Academy of Ophthalmology, Advanced Phacoemulsification, Cornea and Glaucoma Surgery Course. AAO Special Focus Course, Palm Springs California, Course Director. 1998. 21. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. San Francisco, California, 1997. 22. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. San Francisco, California, 1997. 23. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic and Laboratory Course, Course Director. Philadelphia, Pennsylvania, 1997. 24. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. Chicago, Illinois, 1996. 25. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. Chicago, Illinois, 1996. 26. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. Atlanta, Georgia, 1995. 27. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. Atlanta, Georgia, 1995. 28. American Academy of Ophthalmology Skills Transfer Course, Didactic and Laboratory Course of Phacoemulsification. Washington, D.C., 1995. 29. Eye Bank Association of America, Physicians Program, Course Director. Hilton Head, South Carolina, 1995. 30. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. San Francisco, California, 1994. 31. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. San Francisco, California, 1994. 32. Northern Eye Summer Symposium - Update Course, Course Director. Brainerd, Minnesota, 1994. 33. Cornea Federated Societies Meeting (Official Satellite Meeting of the 27th International Congress of Ophthalmology), Program Co-Chair. Toronto, Ontario, Canada, 1994. 34. American Society of Cataract and Refractive Surgery, Transsclerally Sutured Posterior Chamber Lenses. Boston, Massachusetts, 1994. 35. American Academy of Ophthalmology Skills Transfer Course. Didactic and Laboratory Course of Phacoemulsification. Palm Springs, California, 1994. 36. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. Chicago, Illinois, 1993. 37. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Laboratory Course, Course Director. Chicago, Illinois, 1993. 38. Northern Eye Summer Symposium - Update Course, Course Director. Brainerd, Minnesota, 1993. 39. Update on Corneal External Disease, Course Director. Minneapolis, Minnesota, 1993. 40. Contact Lens Association of America Meeting, Immunology Symposium, Symposium Director. Las Vegas, Nevada, 1993. 41. Eye Bank Association of America Annual Scientific Session, Session Chair. Dallas, Texas, 1992. 42. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. Dallas, Texas, 1992. 43. American Academy of Ophthalmology Advanced Anterior Segment Surgery Laboratory Course, Course Director. Dallas, Texas, 1992. 44. Northern Eye Summer Symposium Update Course, Course Director. Brainerd, Minnesota, 1992. 45. Physician's Program, Eye Bank Association of America, Annual Meeting, Course Director. Lake Tahoe, Nevada, 1992. 46. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. Anaheim, California, 1991. 47. American Academy of Ophthalmology Advanced Anterior Segment Surgery Laboratory Course, Course Director. Anaheim, California, 1991. 48. Eye Bank Association of America Annual Scientific Session, Session Chair. Anaheim, California, 1991. 49. Physician's Program, Eye Bank Association of America, Annual Meeting, Course Director. Marco Island, Florida, 1991. 50. American Academy of Ophthalmology Regional Update Course, Course Director. Minneapolis, Minnesota, 1991. 51. Lane SS, Holland EJ, Lindstrom RL. A Survey of Viscoelastic Materials and Their Use in Anterior Segment Surgery. American Academy of Ophthalmology. Las Vegas, Nevada, 1988, New Orleans, Louisiana, 1989, Atlanta, Georgia. 1990. 52. Anterior Segment Immunology and Infectious Disease, Course Director. Minneapolis, Minnesota, April, 1989. 53. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. New Orleans, Los Angeles, 1988. 54. American Academy of Ophthalmology, Advanced Anterior Segment Surgery Didactic Course, Course Director. New Orleans, Los Angeles, 1988. 55. Penetrating Keratoplasty Course. Department of Ophthalmology. University of Minnesota. 1987.1988. Visiting Professor - University of California, San Francisco, San Francisco, California, September 2008. Ohio State University, Columbus, Ohio, May 2005 University of Missouri-Columbia, Columbia, Missouri, November 2004. University of Alberta, Alberta, Edmonton, Canada, May 2003. University of Toronto, Toronto, Ontario, Canada, January 2001. University of Pittsburgh, Pittsburgh, Pennsylvania, December 2000. University of Kentucky, Lexington, Kentucky, September 2000. Wake Forest University, Winston-Salem, North Carolina, January 1999. Cleveland Clinic, Cleveland, Ohio, September 1998. Manhattan Eye, Ear & Throat Hospital, New York City, New York, April 1998. University of California-Davis, Sacramento, California, January 1998. Long Island Jewish Medical Center, New York, November 1997. Tokyo Dental College, Tokyo, Japan, October 1997. University of British Columbia, Vancouver, April 1997. Emory University, Atlanta, Georgia, June 1996 William Beaumont Hospital, Detroit, Michigan, January 1995. New York Eye and Ear Infirmary, New York, New York, December 1994. Seoul National University, Seoul, Korea, September 1994. Cornell University, New York, New York, January 1994. Catholic Medical Center, New York, New York, January 1994. Washington University, St. Louis, Missouri, October 1993. Case Western Reserve University, Cleveland, Ohio, April 1992. University of Washington, Seattle, Washington, March 1990 Mt. Sinai Hospital, Detroit, Michigan, November 1989. Presentations at Major Medical Meetings (183) 1. Cornea Donor Study Outcomes. Cornea Day of American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts. April 2014. 2. Pardon the Ophthalmology: Hot Topics in Cornea and External Diseases. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts. April 2014. 3. From Basic to Advanced: Deep Anterior Lamellar Keratoplasty. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts. April 2014. 4. Results of the Cornea Donor Society. Cornea Society/EBAA Educational Conference. American Academy of Ophthalmology. New Orleans, November 2013. 5. Limbal Stem Cell Deficiency: Diagnosis and Management. American Academy of Ophthalmology: Cornea Day. New Orleans, November 2013. 6. Limbal Stem Cell Transplantation Surgical Techniques. American Academy of Ophthalmology. November 2013. 7. Endothelial Transplantation Complications. American Academy of Ophthalmology. November 2013. 8. Cornea Society Castroviejo Medal Lecture: The Evolution of Lamellar Keratoplasty. American Academy of Ophthalmology. November 2013. 9. AAO Café: Cornea and External Disease. American Academy of Ophthalmology. November 2013. 10. Limbal Stem Cell Failure: Surgical Options. American Academy of Ophthalmology. November 2013. 11. Why DALK, standard technique and long term survival, Transition to DALK. EU Cornea Society. SISCCO Meeting. Sienna, Italy, July 2013. 12. Post Operative complications, Transitioning to DSEK: The Basic. The Cornea Society. SISCCO Meeting. Sienna, Italy, July 2013. 13. Why DALK should be the Procedure of choice of Corneal Stromal disease. American Society of Cataract and Refractive Surgery Annual Meeting: Cornea Day. San Francisco, CA, April 2013. 14. Pardon the Ophthalmology: Hot Topics in Cornea and External Disease. American Society of Cataract and Refractive Surgery Annual Meeting: Cornea Day. San Francisco, CA, April 2013. 15. Limbal Stem Cell Deficiency: Causes and Treatments. American Society of Cataract and Refractive Surgery Annual Meeting: Cornea Day. San Francisco, CA, April 2013. 16. Interactive Cornea. American Society of Cataract and Refractive Surgery Winter Update: Cornea Day. Adventura, FL, February 2013. 17. AM 2013 Highlights, ASCRS Video. American Society of Cataract and Refractive Surgery Winter Update: Cornea Day. Adventura, FL, February 2013. 18. Rapid F-Eye-R: You Make the Call. American Society of Cataract and Refractive Surgery Winter Update: Cornea Day. Adventura, FL, February 2013. 19. Improving Outcomes in Endothelial Keratoplasty. The 3rd Asia Cornea Society Meeting. Manila, Philippines, November 2012. 20. Management of Anterior Segment Inflammation. The 3rd Asia Cornea Society Meeting. Manila, Philippines, November 2012. 21. Ocular Surface Transplantation: Surgical Options and Treatment Paradigm. The 3rd Asia Cornea Society Meeting. Manila, Philippines, November 2012. 22. Advances in Ocular Surface Stem Cell Transplantation. American Academy of Ophthalmology. Chicago, Illinois, November 2012. 23. Diagnosis and Treatment of Ocular Infections-Culture / Susceptibility Testing Are Unnecessary. American Academy of Ophthalmology. Chicago, Illinois, November 2012. 24. Premium IOL Patient Selection: Common Mistakes. American Academy of Ophthalmology. Chicago, Illinois, November 2012. 25. Corneal Surgery for Pediatric Cornea Opacities: Lamellar Surgery is Better. American Academy of Ophthalmology. Chicago, Illinois, November 2012. 26. Limbal Stem Cell Failure & Surgical Options. American Academy of Ophthalmology. Chicago, Illinois, November 2012. 27. AAO Café: Cornea and External Disease. American Academy of Ophthalmology. Chicago, Illinois, November 2012. 28. Vision and Optical Quality in Cataract Surgery with Different Multifocal IOL’s. European Society of Cataract and Refractive Surgeons Meeting. Milan, Italy, September 2012. 29. Limbal Stem Cell Transplant versus Boston Keratoprosthesis in Ocular Surface Disease: How to Choose. European Society of Cataract and Refractive Surgeons Meeting. Milan, Italy, September 2012. 30. Cataract Surgery with Co-Existing Eye Disease. Kiawah Eye Program Committee Meeting. Kiawah Island, South Carolina, May 2012. 31. Interactive Cornea – Case Discussion. Kiawah Eye Program Committee Meeting. Kiawah Island, South Carolina, May 2012. 32. Controversies in Corneal and Ocular Surface Transplantation. American Society of Cataract and Refractive Surgery Annual Meeting: Cornea Day. Chicago, Illinois, April 2012. 33. Cornea Graph Survival on Glaucoma. American Society of Cataract and Refractive Surgery Annual Meeting. Chicago, Illinois, April 2012. 34. Endothelial Transplantation: Latest Trends. American Society of Cataract and Refractive Surgery Annual Meeting. Chicago, Illinois, April 2012. 35. Limbal Stem Cell Transplant vs Keratoprosthesis. American Society of Cataract and Refractive Surgery Annual Meeting: Cornea Day. Chicago, Illinois, April 2012. 36. Deep Anterior Lamellar Keratoplasty Update. American Society of Cataract and Refractive Surgery Annual Meeting. Chicago, Illinois, April 2012. 37. 2012 Review of New Surgical Technologies and Devices: Ocular Surface Transplantation. American Society of Cataract and Refractive Surgery Annual Meeting. Chicago, Illinois, April 2012. 38. Assessment of Safety Outcomes and Contrast Sensitivity in Prospective Phase 2 U.S. Clinical Investigation of Angle- Supported Phakic IOLs. American Society of Cataract and Refractive Surgery Annual Meeting. Chicago, Illinois, April 2012. 39. Limbal Stem Cell Transplantation Procedures. American Academy of Ophthalmology Annual Meeting. Orlando, Florida, October 2011. 40. Issue in Corneal and External Disease. American Academy of Ophthalmology Annual Meeting. Orlando, Florida, October 2011. 41. AAO Café: Cornea and External Disease. American Academy of Ophthalmology Annual Meeting. Orlando, Florida, October 2011. 42. Toric IOLs. Kiawah Eye Meeting. Kiawah, South Carolina, June 2011. 43. Cataract Patient with Ocular Surface Disease. Kiawah, South Carolina, June 2011. 44. Severe OSD - Keratoprosthesis vs. Ocular Stem Cell Transplant. Cornea Day, American Society of Cataract and Refractive Surgery Annual Meeting. San Diego, California, March 2011. 45. Why DALK should be the Procedure of choice for Corneal Stromal Disease. American Society of Cataract and Refractive Surgery Annual Meeting. San Diego California, March 2011. 46. Update on Treatment Strategies for HSV Keratitis American Society of Cataract and Refractive Surgery Annual Meeting. San Diego, California, March 2011. 47. No Spin: PK has been mortally wounded. American Academy of Ophthalmology Annual Meeting. Chicago, Illinois, October 2010. 48. Limbal Transplantation: Surgical Techniques. American Academy of Ophthalmology Annual Meeting. Chicago, Illinois, October 2010. 49. DALK Update. American Academy of Ophthalmology Annual Meeting. Chicago, Illinois, October 2010. 50. AAO Café: Cornea and External Disease. American Academy of Ophthalmology Annual Meeting. Chicago, Illinois, October 2010. 51. Ocular Surface Disease. Clinical Decision-Making and Treatment Options to Maximize Ocular Surface Health. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts, April 2010. 52. Ocular Surface Management in the Surgical Patient. Maximizing Anterior Segment Surgical Outcomes: Therapeutic Considerations and an Update on Clinical Studies. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts, April 2010. 53. DALK for Keratoconus. Deep Anterior Lamellar Keratoplasty Course. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts, April 2010. 54. Update on Clinical Outcomes of Apodized Diffractive IOLs. Physicians Program. Hawaiian Eye Meeting. Koloa, Hawaii, January 2010. 55. Keratoplasty in the Stem-Cell Deficient Ocular Surface. Challenges in Keratoplasty (PAAO) Symposium. American Academy of Ophthalmology Annual Meeting. San Francisco, California, October 2009. 56. Surgical Techniques for Limbal Transplantation. Surgery for Severe Corneal Ocular Surface Disease Course. American Academy of Ophthalmology Annual Meeting. San Francisco, California, October 2009. 57. Keratolimbal Allograft versus Keratoprosthesis. Aniridia Foundation Annual Meeting. Chicago, Illinois, July 2009. 58. Keratoprosthesis Surgery. Aniridia Foundation Annual Meeting. Chicago, Illinois, July 2009. 59. Post Operative Management and Systemic Immunosuppression. Aniridia Foundation Annual Meeting. Chicago, Illinois, July 2009. 60. Stages of Aniridic Keratopathy. Aniridia Foundation Annual Meeting. Chicago, Illinois, July 2009. 61. Update on HSV Keratitis. American Society of Cataract and Refractive Surgeons – Cornea Clinical Committee Highlights Session. American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California, April 2009. 62. Deep Anterior Lamellar Keratoplasty Update Course. American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California, April 2009. 63. Starting a Premium IOL Practice with Toric IOLs. Hawaiian Eye Annual Meeting. Wailea, Maui, Hawaii, January 2009. 64. Surgical Techniques for Limbal Transplantation. Surgery for Severe Corneal and Ocular Surface Disease Course. American Academy of Ophthalmology Annual Meeting. Atlanta, Georgia, November 2008. 65. AAO Café: Cornea and External Disease. American Academy of Ophthalmology Annual Meeting. Atlanta, Georgia, November 2008. 66. Medical and Surgical Management of Ocular Surface Disease: Surgical Therapy. American Society of Cataract and Refractive Surgery Winter Update Meeting. Cancun, Mexico, February 2008. 67. DSEK: Complication Management. American Society of Cataract and Refractive Surgery Winter Update Meeting. Cancun, Mexico, February 2008. 68. Therapeutic Recommendation Before, During & After Refractive Surgery. Physicians program, Hawaiian Eye Meeting. Kailua-Kona, Hawaii, January 2008. 69. NSAIDs Post-Cataract: Do We Really Need Them? Physicians program, Hawaiian Eye Meeting. Kailua-Kona, Hawaii, January 2008. 70. Newer Surgical Management of Corneal Diseases. LEO Clinical Update Course, American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana, November 2007. 71. Diagnosis and Treatment of Limbal Stem Cell Deficiency and other Ocular Surface Diseases. LEO Clinical Update Course, American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana, November 2007. 72. Management of Astigmatism and Optimizing the Ocular Surface for Anterior Segment Surgery. Cornea Committee Symposium, American Society of Cataract and Refractive Surgery Annual Meeting. San Diego, California, April 2007. 73. Diagnosis and Treatment of Limbal Stem Cell Deficiency and other Ocular Surface Diseases. LEO Clinical Update Course, American Academy of Ophthalmology Annual Meeting. Las Vegas, California, November 2006. 74. Advanced Keratoplasty Course. American Academy of Ophthalmology Annual Meeting. Las Vegas, California, November 2006. 75. Keratorefractive and Corneal Disease. American Academy of Ophthalmology Board of Trustees Meeting. San Francisco, California, September 2006. 76. Corneal Transplantation-Management of Graft Rejection. American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California, March 2006. 77. New Trends in Management of Microbial Keratitis. Cornea Day, American Society of Cataract and Refractive Surgery Meeting. San Francisco, California, March 2006. 78. The Role of the Medical Director in Quality Assurance. Session CO 29, World Congress Ophthalmology Meeting. Sao Paulo, Brazil, February 2006. 79. Ocular Penetration of Topical Antibiotics. Session CO 14, World Congress Ophthalmology Meeting. Sao Paulo, Brazil, February 2006. 80. Techniques and Outcomes of Stem Cell Transplantation for Ocular Surface Disease. Session CO 02, World Congress Ophthalmology Meeting. Sao Paulo, Brazil, February 2006. 81. Overview of the Management of Severe Ocular Surface Disease. Session PP 01, World Congress Ophthalmology Meeting. Sao Paulo, Brazil, February 2006. 82. NSAID’s: New Agents and Changing Indications. Physicians Program, Hawaiian Eye Meeting. Maui, Hawaii, January 2006. 83. Managing the Abnormal Corneal Surface. Spotlight on Cataract Surgery 2005, American Academy of Ophthalmology Annual Meeting. Chicago, Illinois, October 2005. 84. Maximizing Surgical Outcomes with Target-Specific Therapy. American Academy of Ophthalmology Annual Meeting. Chicago, Illinois, October 2005. 85. Update on Keratoprosthetic Devices. Physician Program, Eye Bank Association Annual Meeting. Tucson, Arizona, June 2005. 86. Management of Pterygium. Discussion. American Ophthalmological Society Annual Meeting. Sea Island, Georgia, May 2005. 87. Phase I Clinical Trial Results of the XACT Hydrophobic, High-Refractive-Index Acrylic IOL. American Society of Cataract and Refractive Surgery Annual Meeting. Washington, D.C., April 2005. 88. The Best of the World Cornea Congress V. Symposium, American Society of Cataract and Refractive Surgery. Washington, D.C., April 2005. 89. LASIK Top Ten Pearls from the Experts. American Society of Cataract and Refractive Surgery. Washington, D.C., April 2005. 90. Management of Graft Rejection: Mild, Moderate, and Severe. Cornea Transplantation – The Requisites Symposium, American Society of Cataract and Refractive Surgery. Washington, D.C., April 2005. 91. Pearls in the Medical and Surgical Management of Corneal Disease. Ask the Experts Symposium, American Society of Cataract and Refractive Surgery. Washington, D.C., April 2005. 92. Ocular Surface Transplantation: Current Techniques and Outcomes. World Cornea Congress Meeting V. Washington, D.C., April 2005. 93. Dry Eye Management Strategies: 2005. Physicians Program, Hawaiian Eye Meeting. Waikoloa Village, Hawaii, January 2005. 94. Advanced Keratoplasty Technique. American Academy of Ophthalmology, Advanced Lab Course. New Orleans, Louisiana, October, 2004. 95. Advanced Keratoplasty Technique. American Academy of Ophthalmology, Advanced Didactic Course. New Orleans, Louisiana, October, 2004. 96. Triple Procedure: Should It Be Staged? Keranet Live Symposium sponsored by The Cornea Society, American Society of Cataract and Refractive Surgery. San Diego, California, May 2004. 97. New Immodulators and Antimetabolites in the Management of Corneal Disease. Hot Topics Symposium, American Society of Cataract and Refractive Surgery. San Diego, California, May 2004. 98. Techniques & Results of the Surgical Orientation of the AcrySof Toric IOL’s. Cataract, IOL, and Refractive Surgery Symposium, American Society of Cataract and Refractive Surgery. San Diego, California, May 2004. 99. Ocular Penetration of Topical Fluoroquinolones. Slack Educational Fluoroquinolone Symposium, American Academy of Ophthalmology. Anaheim, California, November 2003. 100. Keratolimbal Allograft. The Cornea Society Symposium, American Academy of Ophthalmology. Anaheim. California, November 2003. 101. When to Remove the Cataract: Combined vs. Staged Procedures. Symposium, American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California, April 2003. 102. Ocular Surface Transplantation. Symposium, American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California, April 2003. 103. Persistent Epithelial Defects and Ocular Surface Reconstruction. LEO Clinical Update Course, Cornea and External Disease, American Academy of Ophthalmology. Orlando, Florida, October 2002. 104. Microbial Keratitis. LEO Clinical Update Course, Cornea and External Disease, American Academy of Ophthalmology. Orlando, Florida, October 2002. 105. Microbial Keratitis. LEO Clinical Update Course, Cornea and External Disease, American Academy of Ophthalmology. Orlando, Florida, October 2002. 106. What’s New in Corneal Transplants? Castroviejo Cornea Society Symposium. American Academy of Ophthalmology. Orlando, Florida, October 2002. 107. Advanced Keratoplasty Technique. American Academy of Ophthalmology, Advanced Lab Course. Orlando, Florida, October, 2002. 108. Advanced Keratoplasty Technique. American Academy of Ophthalmology, Advanced Didactic Course. Orlando, Florida, October, 2002. 109. Medical Advisory Board Summary. Eye Bank Association of America 41st Annual Meeting. June 2002. 110. Opportunistic Infections. ASCRS Meeting. Philadelphia, Pennsylvania, June 2002. 111. Future Trends in the Management of Cornea and External Disease. Symposium of the International Ocular Surface Society (IOSS). São Paulo, Brazil, February 2002. 112. Strategies for Ocular Surface Transplantation. Symposium of the International Ocular Surface Society (IOSS). São Paulo, Brazil, February 2002. 113. Herpes Simplex Keratitis: Classification and Diagnosis. Castroviejo Cornea Symposium. São Paulo, Brazil, February 2002. 114. Management of the Unhappy Refractive Surgery Patient. Castroviejo Cornea Symposium, American Academy of Ophthalmology. New Orleans, Louisiana, November 2001. 115. Combination KLAL and LR-CLAL for Severe Conjunctival and Limbal Stem Cell Deficiency. The Castroviejo Cornea Society. New Orleans, Louisiana, November 2001. 116. Microbial Keratitis. Refractive Surgery 2001 Subspecialty Day Meeting, American Academy of Ophthalmology. New Orleans, Louisiana, November 2001. 117. Medical Advisory Board Summary. Eye Bank Association of America 40th Annual Meeting. Tucson, Arizona, June 2001. 118. Treating Corneal Diseases with Lotepredinol Etabonate. ASCRS Meeting. San Diego, California, April 2001. 119. Update on Ocular Surface Transplantation. 6th Annual Ophthalmology Clinical Conference and Research Symposium. March 2001. 120. Ocular Surface Reconstruction. American Academy of Ophthalmology. Dallas, Texas, October 2000. 121. Diffuse Lamellar Keratitis Related to Endotoxins Released from Sterilizer Reservoir Biofilms. Discussion. American Academy of Ophthalmology. October 1999. 122. Living-Related Conjunctival-Limbal Allograft for the Treatment of Stem Cell Deficiency. Discussion. American Academy of Ophthalmology. October 1999. 123. Improving Outcomes of Ocular Surface Disease. Castroviejo Cornea Society Symposium, American Academy of Ophthalmology. Orlando, Florida, October 1999. 124. Diagnosis and Treatment of Ulcerative Keratitis. Department of Ophthalmology University of Minnesota Continuing Medical Educational Course. Minneapolis, Minnesota, March, 1999. 125. Surgical Decisions in the Management of Ocular Surface Disease. American Academy of Ophthalmology, Advanced Anterior Segment Course. Palm Springs, California, February 1998. 126. Ocular Surface Transplantation Allograft Procedures. American Academy of Ophthalmology, Advanced Anterior Segment Course. Palm Springs, California, February 1998. 127. Ocular Surface Transplantation Autograft Procedures. American Academy of Ophthalmology, Advanced Anterior Segment Course. Palm Springs, California, February 1998. 128. Update on Techniques for Transsclerally Sutured Posterior Chamber Lenses. American Academy of Ophthalmology, Advanced Anterior Segment Course. Palm Springs, California, February 1998. 129. Epithelial Transplantation for the Management of Severe Ocular Surface Disease. Castroviejo Cornea Society Symposium, American Academy of Ophthalmology. San Francisco, California, October 1997. 130. Overview of the Eye Bank Association of America Medical Standards, EBAA Annual Meeting. Palm Beach Florida, June1997. 131. Iatrogenic Stem Cell Deficiency. American Ophthalmological Society Annual Meeting. Monterey, California, May 1997. 132. Medical Standards Update, Eye Bank Association of America Annual Meeting. Palm Beach, Florida, June 1997. 133. Iatrogenic Stem Cell Deficiency, American Ophthalmological Society. Monterey, California, May 1997. 134. Update on Antivirals. Department of Ophthalmology University of Minnesota Continuing Medical Educational Course. Minneapolis, Minnesota, April 1997. 135. Surgical Options in the Management of Cornea and External Disease. Department of Ophthalmology University of Minnesota Continuing Medical Educational Course. Minneapolis, Minnesota, April 1997. 136. Keratolimbal Allograft for the Management of Ocular Surface Disease. Eye Bank Association of America Annual Meeting. Chicago, Illinois, October 1996. 137. Limbal Stem Transplantation (discussion). American Academy of Ophthalmology, Annual Meeting. Atlanta, Georgia, October 1995. 138. Strategies for the Prevention of Corneal Transplant Rejection. Annual Meeting of the Eye Bank Association of America. Hilton Head, South Carolina, June 1995. 139. Corneal Transplantation in the Pediatric Patient. Department of Ophthalmology University of Minnesota Continuing Medical Education Course. Minneapolis, Minnesota, May 1995. 140. Intraocular Lens Implantation in Juvenile Rheumatoid Arthritis. ARVO Meeting. Ft. Lauderdale, Florida, May 1995. 141. Gonioscopic Evaluation of Haptic Position in Transsclerally Fixated Posterior Chamber Lenses.The Castroviejo Cornea Society Annual Meeting. San Francisco, California, October 1994. 142. Medical Standards Update in Eye Banking. Annual Meeting of the Eye Bank Association of America. Toronto, Canada, June 1994. 143. Primary and Secondary Transsclerally Fixation of Posterior Chamber Lens. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts, April 1994. 144. Discussion of Prospective Clinical Trial of Automated Lamellar Keratoplasty for the Reduction of Myopia and Hyperopia. American Academy of Ophthalmology. Chicago, Illinois, November 1993. 145. Effect of Topically Administered Platelet-Derived Growth Factor on Corneal Wound Strength in Penetrating Keratoplasty, ARVO Meeting. Sarasota, Florida, May 1993. 146. Conjunctival Transplant and Keratoepithelioplasty. Department of Ophthalmology, University of Minnesota, Continuing Medical Education Course. Minneapolis, Minnesota, April 1993. 147. Immunosuppressive Agents for Anterior Segment Inflammatory Disease. Department of Ophthalmology, University of Minnesota, Continuing Medical Education Course. Minneapolis, Minnesota, April 1993. 148. Peripheral Corneal Thinning Disorders. Department of Ophthalmology, University of Minnesota, Continuing Medical Education Course. Minneapolis, Minnesota, April 1993. 149. Conjunctival Transplant and Keratoepithelioplasty. American Academy of Ophthalmology Advanced Anterior Segment Surgery Didactic Course. Dallas,Texas, November 1992. 150. Update on Transscleral - sutured Posterior Chamber Lenses. Northern Eye Summer Symposium. Brainerd, Minnesota, July 1992. 151. High Risk Keratoplasty. EBAA Annual Meeting, Lake Tahoe, Nevada, June 1992. 152. The Synergistic Action of Cyclosporine A and 15-Deoxyspergualin: Prolongation of Allograft Survival in the Rat Orthotropic Penetrating Keratoplasty Model. ARVO Meeting. Sarasota, Florida, May 1992. 153. Collagen Vascular Disease. American Academy of Ophthalmology Annual Meeting. Anaheim, California, October 1991. 154. Clinical Results of Topical Cyclosporine in Anterior Segment Inflammatory Disease. The Castroviejo Corneal Society 17th Annual Meeting. Anaheim, California, October 1991. 155. Management of Pseudophakic Corneal Edema. EBAA Annual Meeting. Marco Island, Florida, June 1991. 156. Update in Keratoplasty Techniques. American Academy of Ophthalmology Regional Update Course. Minneapolis, Minnesota, June 1991. 157. Herpes Simplex Keratitis. American Academy of Ophthalmology Regional Update Course. Minneapolis, Minnesota, June 1991. 158. Corneal Transplantation in the Pediatric Age Group. Department of Ophthalmology, University of Minnesota Continuing Medical Education Course. Minneapolis, Minnesota, April 1991. 159. An Evaluation of Mizoribine and Cyclosporine in the Rat Penetrating Keratoplasty Model, ARVO Meeting. Sarasota, Florida, May 1991. 160. Avellino Corneal Dystrophy. The Castroviejo Cornea Society Sixteenth Annual Meeting. Atlanta, Georgia, October 1990. 161. Anterior Stromal Infiltrates in Acanthamoeba Keratitis. Twenty-fourth Annual Ocular Microbiology and Immunology Group. Atlanta, Georgia, October 1990. 162. Cyclosporin in Anterior Segment Inflammatory Disease. Eye Bank Association of America Annual Meeting. Seattle, Washington, June 1990. 163. What’s New in Corneal Transplant Rejection, North Central Regional Eye Bank Meeting. Madison, Wisconsin, May 1990. 164. Anterior Segment Trauma. Department of Ophthalmology, University of Minnesota Continuing Medical Education Course. April 1990. 165. Ocular Manifestations of Rheumatologic Disease. Rheumatology Conference, University of Minnesota, Minneapolis, Minnesota.January 31, 1990. 166. Differential Diagnosis of Cornea and External Inflammation. Department of Medicine Grand Rounds, University of Minnesota. Minneapolis, Minnesota. November 1989. 167. Surgical Correction of Juvenile Aphakia. American Academy of Ophthalmology, Annual Meeting. New Orleans, Louisiana. November 1989. 168. Modification of Corneal MHC Antigen Expression by Various Corneal Storage Methods. North Central Regional Eye Bank Meeting. Minneapolis, Minnesota. August 1989. 169. Human Corneal Endothelial Transplantation in the Rat Penetrating Keratoplasty Model. ARVOMeeting. Sarasota, FL. May 1989. 170. Studies in Corneal Transplant Rejection, U.S. Japan Ocular Immunology Symposium. Honolulu, Hawaii. April 1989. 171. Surgical Decisions in Anterior Segment Inflammatory and Infectious Disease. University of Minnesota, Department of Ophthalmology, Continuing Medical Education Course. Minneapolis, Minnesota. April 1989. 172. Corneal Transplant Rejection. Department of Ophthalmology, University of Minnesota Continuing Medical Education Course. Minneapolis, Minnesota. April 1989. 173. Ligneous Conjunctivitis: Immunohistologic Findings and a New Treatment. Ocular Microbiology and Immunology Group Meeting. Las Vegas, Nevada, October 1988. 174. Infectious Keratitis in Contact Lens Wearers. Advanced Contact Lens Symposium. Minneapolis, Minnesota. August 1988. 175. Diagnosis and Treatment of Ocular Inflammatory Disease. Midwest Region Continuing Education Program for Ophthalmic Technicians. St. Paul, Minnesota. May 1988. 176. Corneal Transplantation: Preoperative Evaluation and Surgical Technique. Midwest Region Continuing Education Program for Ophthalmic Technicians. St. Paul, Minnesota, May 1988. 177. Kinetics of Corneal Transplant Rejection in the Rat Penetrating Keratoplasty Model, ARVO Meeting. Sarasota, Florida. May, 1988. 178. Suramin Keratopathy, American Academy of Ophthalmology Annual Meeting. Dallas, Texas. October 1987. 179. Clinical and Immunohistologic Studies of Corneal Rejection in the Rat Penetrating Keratoplasty Model, ARVO Meeting. Sarasota, Florida, May 1987. 180. Corneal Thickness in Keratoconus, ARVO Meeting. Sarasota, Florida, May 1986. 181. The Effect of Organ Culture Cornea Preservation on Langerhans Cells, ARVO Meeting. Sarasota, Florida, May 1985. 182. Evaluation of the Major Histocompatibility Antigens in Corneal Allograft Rejection Using a Heteroptopic Murine Model, ARVO Meeting. Sarasota, Florida, May 1984. 183. HLA-B27, Klebsiella Pneumoniae and the Relation to Acute Anterior Uveitis, ARVO Meeting. Sarasota, Florida. May 1981. Invited Lectures (242) 1. Management of High Astigmatism in Cataract Surgery. APACRS Meeting. Seoul, Korea. October 2011. 2. Advances in the Management of Severe Ocular Surface Disease. APACRS Meeting. Seoul, Korea. October 2011. 3. Steven Johnson-Syndrome and Toxic Epidermal Necrolysis. ESCRS Meeting. Vienna, Austria. September 2011. 4. Limbal Transplantation Update. ESCRS Meeting. Vienna, Austria. September 2011. 5. Advanced Corneal Surgery Utilizing the Femto-Second Laser. Asian Cornea Society Meeting. Kyoto, Japan. December 2010. 6. Ocular Surface Reconstruction: Keratoprosthesis vs. Ocular Surface Transplantation. Asian Cornea Society Meeting. Kyoto, Japan. December 2010. 7. Safety and Efficacy of Systemic Immunosuppression for Ocular Surface Transplantation. Asian Cornea Society Meeting. Kyoto, Japan. December 2010. 8. Management of Astigmatism in Cataract Surgery. Asian Cornea Society Meeting. Kyoto, Japan. December 2010. 9. Diagnosis and Management of Peripheral Corneal Thinning Disorders. Kiawah Eye Meeting. Kiawah, South Carolina. May 2010. 10. Why all Surgeons Should Be Using Toric IOLs. Kiawah Eye Meeting. Kiawah, South Carolina. May 2010. 11. The Femtosecond-Laser Assisted Cataract Surgery System. Kiawah Eye Meeting. Kiawah, South Carolina. May 2010. 12. Assessment of Intraoperative Wavefront Aberrometer for Determining Appropriate IOL Power in Aphakic Eyes. Intraocular Surgery IOL Metrics and Power Session 3E. American Society of Cataract and Refractive Surgeons Annual Meeting. Boston, Massachusetts. April 2010. 13. Recent Advances in Surgical Management of Stem-Cell Deficiency. World Cornea Congress Meeting VI. Boston, Massachusetts. April 2010. 14. AAO Café: Cornea and External Disease. Moderator for Case Discussions. American Academy of Ophthalmology Annual Meeting. San Francisco, California. October 2009. 15. The Importance of the Ocular Surface: The Whitney Sampson Lecture, American Academy of Ophthalmology Annual Meeting. San Francisco, California. October 2009. 16. A Decade of Systemic Immunsuppression in Patients Receiving Ocular Surface Transplants. The Federated Symposium on Eye Banking and Cornea. American Academy of Ophthalmology Annual Meeting. San Francisco, California. October 2009. 17. Keratolimbal Stem Cell Transplantation: Why, When, and How? First Scandinavian Symposium. Gothenburg, Sweden. March 2009. 18. The Effect of the Cornea Donor Age on Corneal Transplantation Outcome: Results of the Cornea Donor Study. The Cornea Society/Eye Bank Association of America Symposium. Atlanta, Georgia. November 2008. 19. Ocular Surface Reconstruction. Annual Ophthalmology Meeting. University of California, Irvine, Irvine, California. October 2008. 20. Corneal Challenges. Annual Ophthalmology Meeting. University of California, Irvine, Irvine, California. October 2008. 21. Update in Corneal Transplantation.Grand Rounds, Department of Ophthalmology and Ocular Oncology. Jagiellonian University Medical College. Krakow, Poland. September 2008. 22. Ocular Surface Disease. Grand Rounds, Department of Ophthalmology, Medical University of Warsaw. Warsaw, Poland. September 2008. 23. Results of the CDS Study. Eye Bank Association of America Annual Meeting. Hollywood, Florida. June 2008. 24. Management of Corneal Disease in Cataract Surgery. Wet Lab Course, RANZCO Annual Congress. Perth, Western Australia. November 2007. 25. Is Ectasia an Unexplained Consequence of Refractive Surgery/Ectasia Treatment. RANZCO Annual Congress. Perth, Western Australia. November 2007. 26. New Innovations in Corneal Surgery. RANZCO Annual Congress. Perth, Western Australia. November 2007. 27. 2D Astigmatism: Why Toric IOLs. Spotlight on Cataracts 2007: Current Controversies in Cataract Surgery, American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana. November 2007. 28. Stem Cell Survival: Tissue Typing and Immunosuppressive Regimens. Cornea 2007: Contemporary and Future Issues Subspecialty Day, American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana. November 2007. 29. Ectasia: How to Prevent It, How to Manage It. Refractive Surgery 2007 Subspecialty Day, American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana. November 2007. 30. Boston Keratoprosthesis: Surgical Techniques and Results. VI Congress S.I.C.S.S.O. Meeting. Puglia, Italy. June 2007. 31. Endothelial Keratoplasty Techniques, Complications, and Outcomes. VI Congresso S.I.C.S.S.O. Meeting. Puglia, Italy. June 2007. 32. Ocular Surface Transplantation: Overview and Current State of the Field. SOE American Academy of Ophthalmology Congress. Vienna, Austria. June 2007. 33. Techniques and Outcomes in Stem Cell Transplantation for Ocular Surface Disease. SOE American Academy of Ophthalmology Congress. Vienna, Austria. June 2007. 34. Infectious Keratitis in Refractive Surgery. 2006 Clinical Update Meeting. Storm Eye Institute, Kiawah. South Carolina, May 2006. 35. Advances of Anterior Segment Surgery. Lexington Academy of Ophthalmology Meeting. Lexington, Kentucky. November 2005. 36. Management of Microbial Keratitis. GESOC Cornea Surface Meeting. Barcelona, Spain. March 2005. 37. Cataract Surgery and Corneal Disease. GESOC Cornea Surface Meeting. Barcelona, Spain. March 2005. 38. Ocular Surface Transplantation. GESOC Cornea Surface Meeting. Barcelona, Spain. March 2005. 39. Ocular Surface Transplantation. New York Academy of Medicine Meeting. New York, New York. February 2005. 40. Dry Eye Management Strategies: 2005. Physicians Program, Hawaiian Eye Meeting. Waikoloa Village, Hawaii. January 2005. 41. The Artificial Iris in Cataract Surgery. Annual Clinic Day, The Nassau Surgical Society Brooklyn & Long Island Chapters of The American College of Surgeons. Long Island, New York. December 2004. 42. Treatment Guidelines for Patients with Severe Ocular Surface Disease. Annual Clinic Day, The Nassau Surgical Society Brooklyn & Long Island Chapters of The American College of Surgeons. Long Island, New York. December 2004. 43. Diagnosis and Management of Herpes Simplex Keratitis. The 2nd Annual John Aure Buesseler, MD Visiting Professorship, Mason Eye Institute, University of Missouri-Columbia. Columbia, Missouri. November 2004. 44. Management of Ocular Surface Disease. The 2nd Annual John Aure Buesseler, MD Visiting Professorship, Mason Eye Institute, University of Missouri-Columbia. Columbia, Missouri. November 2004. 45. Current Innovations in Cataract Surgery. The Fifth International Conference “Modern Technologies in Cataract Surgery – 2004.” Moscow, Russia. November, 2004. 46. Management of Coexisting Cataract and Corneal Disease. The Fifth International Conference “Modern Technologies in Cataract Surgery – 2004.” Moscow, Russia. November, 2004. 47. Superior Corneal Epitheliopathy. 2004 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2004. 48. Microbial Keratitis. 2004 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. June 2004. 49. Corneal Transplants, the Good, the Bad, and the Ugly. The Christ Hospital Ophthalmic Symposium. Cincinnati, Ohio. November 2003. 50. Peri-operative Antimicrobial Prophylaxis for Anterior Segment Surgery. The 26th Annual Ophthalmology Symposium and Resident’s Day. Napa, California. June 2003. 51. Corneal Complications of Cataract Surgery. Eye on Napa 2003: Prevention and Management of Complications in Ophthalmic Surgery. The 26th Annual Ophthalmology Symposium and Resident’s Day. Napa, California. June 2003. 52. S.I.C.S.S.O. XV I.O.S.S. International Meeting, Erice. Sicily, Italy. June 2003. 53. Keratolimbal Allograft: Suggested Techniques and Tissue needs. Technician Forum Luncheon, 42nd Annual Eye Bank Association of America Meeting. Washington, D.C. June 2003. 54. Ocular Surface Transplantation. Innovative Surgery in Selective Corneal Transplantation and Ocular Surface Repair Symposium. Fourteenth Congress of the European Society of Ophthalmology. Madrid, Spain. June 2003. 55. The Ocular Surface and the Refractive Surgery. II Congresso Nazionale S.I.C.S.S.O. XV I.O.S.S. International Meeting. Erice, Sicily, Italy. June 2003. 56. Management of HSV Keratitis. 2003 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2003. 57. What’s New in Ocular Antibiotics Part 1. 2003 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2003. 58. Superior Corneal Epitheliopathy. 2003 Clinical Update Meeting. Storm Eye Institute, Charleston, South Carolina. May 2003. 59. Bacterial Infections after RK, PRK, and LASIK. 2003 Clinical Update Meeting. Storm Eye Institute, Charleston, South Carolina. May 2003. 60. Pro/Con: CK vs. LASIK. 2003 Clinical Update Meeting. Storm Eye Institute, Charleston, South Carolina. May 2003. 61. Pro/Con: Intralase vs. Microkeratomes. 2003 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2003. 62. Ocular Surface Transplantation. 2003 Resident Research Day, Department of Ophthalmology, University of Alberta. Edmonton, Canada. May 2003. 63. HSV Keratitis. 2003 Resident Research Day, Department of Ophthalmology, University of Alberta. Edmonton, Canada. May 2003. 64. Peripheral Corneal Thinning Disorders. 2003 Resident Research Day, Department of Ophthalmology, University of Alberta. Edmonton, Canada. May 2003. 65. Principals of Management and Choice of Procedures. The Royal College of Ophthalmologists Annual Congress. Birmingham, England. May 2003. 66. LASIK Complications. Frontiers in Ophthalmology 2003 Conference. Paradise Valley, Arizona. February 2003. 67. Management of Microbial Keratitis. Frontiers in Ophthalmology 2003 Conference. Paradise Valley, Arizona. February 2003. 68. Management of Ocular Surface Disease. Frontiers in Ophthalmology 2003 Conference. Paradise Valley, Arizona. February 2003. 69. Post-operative Management Following Stem Cell Transplantation. Stem Cell Restoration Symposium, Cornea 2002 Meeting. London, England. November 2002. 70. Selection of the Appropriate Stem Cell Transplant Procedure. Stem Cell Restoration Symposium, Cornea 2002 Meeting. London, England. November 2002. 71. Clinical Aspects of Ocular Surface Stem Cell Transplantation. Stem Cells: What Are They and How Might They be Used for Ocular Disease Treatment Symposium, The American Ophthalmological Society One Hundred and Thirty-Eighth Annual Meeting. Sea Island, Georgia. May 2002. 72. Management of Aniridia. 2002 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2002. 73. Update on Ocular Surface Transplantation. 2002 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2002. 74. Herpes Simplex Keratitis: Classification and Treatment. 2002 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2002. 75. Strategies for Antibiotic Prophylaxis in Anterior Segment Surgery. 2002 Clinical Update Meeting, Storm Eye Institute. Charleston, South Carolina. May 2002. 76. Herpes Simplex Keratitis. Memphis Eye Convention, University of Tennessee. Nashville, Tennessee. April 2002. 77. Management of Peripheral Ulcerative Keratitis. Memphis Eye Convention, University of Tennessee. Nashville, Tennessee. April 2002. 78. Chronic Conjunctivitis. Memphis Eye Convention, University of Tennessee. Nashville, Tennessee. April 2002. 79. HSV Keratitis. University of Wisconsin, Medical College Grand Rounds Lecture. Milwaukee, Wisconsin. March 2002. 80. Ocular Surface Transplantation. Milwaukee Ophthalmological Society Meeting. Milwaukee, Wisconsin. March 2002. 81. Corneal Issues/Cataract Surgery. Ohio Ophthalmological Society Clinical Meeting. Columbus, Ohio. February 2002. 82. Penetration in the Cornea Tissue and the Use of Fluoroquinolones in Keratoplasty. Ophthalmic Therapeutics: The Surgeon’s Fluoroquinolone, Hawaii 2002. Waikoloa, Hawaii. January 2002. 83. Intraoperative Complications of LASIK Surgery. University of Toronto. Toronto, Ontario, Canada. December 2001. 84. Growth Transplantation: Indications for Surgery. 55th Congress of Clinical Ophthalmology of Japan. Kyoto, Japan. October 2001. 85. Stem Cell Transplantation, Keynote Lecture. 55th Congress of Clinical Ophthalmology of Japan. Kyoto, Japan. October 2001. 86. Immunosuppression in Ocular Surface Reconstruction. The Royal College of Ophthalmologists, Seminar Program. Regents Park, London, England. September 2001. 87. Algorithm for the Selection of Ocular Surface Transplantation Techniques. The Royal College of Ophthalmologists, Seminar Programme. Regents Park, London, England. September 2001. 88. Cornea Case Studies. Michigan Ophthalmological Society’s 33rd Annual Conference. Grand Traverse, Michigan. August 2001. 89. Diagnosis and Management of Peripheral Ulcerative Keratitis. Michigan Ophthalmological Society’s 33rd Annual Conference. Grand Traverse, Michigan. August 2001. 90. Management of Ocular Surface Disease. Michigan Ophthalmological Society’s 33rd Annual Conference. Grand Traverse, Michigan. August 2001. 91. Peripheral Ulcerative Keratopathy: Diagnosis and Management. Thorny Issues in Ophthalmology Conference. June 2001. 92. Ocular Surface Problems in Refractive Surgery. Rome Symposium on Cataract, Glaucoma and Refractive Surgery. May 2001. 93. Update on Ocular Surface Transplantation. Minnesota Academy of Ophthalmology. St. Paul, Minnesota. April 2001. 94. Peripheral Ulcerative Keratitis: Diagnosis and Management. 44th Annual Postgraduate Symposium in Ophthalmology, Ohio State University. Columbus, Ohio. March 2001. 95. Management of Pterygium. 44th Annual Postgraduate Symposium in Ophthalmology, Ohio State University. Columbus, Ohio. March 2001. 96. Herpes Simplex Keratitis. 44th Annual Postgraduate Symposium in Ophthalmology, Ohio State University. Columbus, Ohio. March 2001. 97. Ocular Surface Transplantation. 44th Annual Postgraduate Symposium in Ophthalmology, Ohio State University. Columbus, Ohio. March 2001. 98. Ocular Surface Transplantation. Nashville Academy of Ophthalmology. Nashville, Tennessee. January 2001. 99. Ocular Surface Transplantation. Visiting Professor Rounds, University of Toronto. Toronto, Ontario, Canada. January 2001. 100. Ocular Surface Transplantation. Ophthalmology Grand Rounds and Lectureship, University of Utah School of Medicine, John Moran Eye Center. Salt Lake City, Utah. January 2001. 101. Herpes Simplex Keratitis. Pittsburgh Ophthalmology Society. Pittsburgh, Pennsylvania. December 2000. 102. Ocular Surface Transplantation. Pittsburgh Ophthalmology Society. Pittsburgh, Pennsylvania. December 2000. 103. Stem Cells Transplantation - Amniotic Membrane Transplantation. IX Oslo Symposium in Ophthalmology. Oslo, Norway. December 2000. 104. Systemic Immunsuppression following Limbal Stem Cell Transplantation. Patologia della Superficie Oculare. Castiglione della Pescaia, Italy. October 2000. 105. Combined KLAL and CLAL videotape. Patologia della Superficie Oculare. Castiglione della Pescaia, Italy. October 2000. 106. Surgical decision making for a Limbal Stem Cells Transplantation. Patologia della Superficie Oculare. Castiglione della Pescaia, Italy. October 2000. 107. Treatment of LASIK Complications, Refractive Surgery and Refractive Aspects of Cataract Surgery. University of Cincinnati. Cincinnati, Ohio. June 2000. 108. Management of Corneal Disease in the Next Millennium. Chicago Ophthalmic Society. Chicago, Illinois. June 2000. 109. ISPB Lecture: Ocular Surface Transplantation. Chicago Ophthalmic Society. Chicago, Illinois. June 2000. 110. Diagnosis and Therapy of Peripheral Ulcerative Keratitis. Chicago Ophthalmic Society. Chicago, Illinois. June 2000. 111. Management of Post Keratoplasty Astigmatism. Chicago Ophthalmic Society. Chicago, Illinois. June 2000. 112. Management of LASIK Complications. Chicago Ophthalmic Society. Chicago, Illinois. June 2000. 113. Classification of Ocular Surface Transplantation. International Ocular Surface Society. Guainía, Brazil. April 2000. 114. Surgical Management of Aniridic Keratopathy. Ocular Surface Symposium. Guainía, Brazil. April 2000. 115. Systemic Immunosuppression and the Management of Stem Cell Trans-plantation. International Ocular Surface Society Annual Meeting. Guainía, Brazil. April 2000. 116. Ocular Surface Disease. Medical and Surgical Management. Wills Eye Hospital. Philadelphia, Pennsylvania. April 2000. 117. Diagnosis and Management of Peripheral Ulcerative Keratitis. Wills Eye Hospital. Philadelphia, Pennsylvania. April 2000. 118. Ocular Surface Disease. Seattle Ophthalmologic Society. Seattle, Washington. February 2000. 119. Diagnosis and Management of Ocular Surface Disease. Phoenix Ophthalmological Society. Phoenix, Arizona. December 1999. 120. Clinical Manifestations of Herpes Simplex Keratitis, III Pan-American Association of Eye Banks. Sao Paulo, Brazil. November 1999. 121. The Success of the Eye Bank System in North America, III Pan-American Association of Eye Banks. Sao Paulo, Brazil. November 1999. 122. The Evolution of Epithelial Transplantation for Ocular Surface Disease and a Proposed Classification System. Il Trapianto di Cornea Complication Scientific Session. Castiglione della Pescaia, Italy. October 1999. 123. Keratolimbal Allograft for the Treatment of Limbal Stem Cell Deficiency. The Castroviejo Cornea Society Twenty-Fifth Annual Meeting. Orlando, Florida. October 1999. 124. Corneal Degenerations, Pterygium and Tumors, Sally Letson Symposium, University of Ottawa. Ottawa, Canada. September 1999. 125. Management of Ocular Surface Disease, Sally Letson Symposium, University of Ottawa. Ottawa, Canada. September 1999. 126. Peripheral Ulcerative Keratitis, Sally Letson Symposium, University of Ottawa. Ottawa, Canada. September 1999. 127. Stem Cell Transplantation in Severe Ocular Surface Disease, Grand Rounds, National Eye Institute. Bethesda, Maryland. August 1999. 128. Treatment of Herpes Simplex Keratitis, San Diego Eye Bank, Current Concepts in Ophthalmology. San Diego, California. July 1999. 129. Peripheral Ulcerative Keratitis Diagnosis and Management, San Diego Eye Bank, Current Concepts in Ophthalmology. San Diego, CA. July 1999. 130. Chronic Conjunctivitis, San Diego Eye Bank, Current Concepts in Ophthalmology. San Diego, California. July 1999. 131. Reconstruction with Keratolimbal Allograft Technique. 4th Ocular Surface and Tear Conference, Bascom Palmer Eye Institute. Miami, Florida. May 1999. 132. Diagnosis and Treatment of Viral Keratitis. Cincinnati Society of Ophthalmology. Cincinnati, Ohio. April 1999. 133. Management of Severe Ocular Surface Disease. Cincinnati Society of Ophthalmology. Cincinnati, Ohio. April 1999. 134. Ocular Surface Reconstruction, Wake Forest University, Winston-Salem, North Carolina, January 1999. 135. HSV Keratitis, Wake Forest University, Winston-Salem, North Carolina, January 1999. 136. Keratolimbal Allograft (KLAL) for the Management of Aniridic Keratopathy. The Castroviejo Cornea Society, New Orleans, Louisiana, November 1998. 137. Oral Acyclovier for the Management of Herpes Simplex Virus (HSV) Infectious Epithelial Keratitis in Children. The Castroviejo Cornea Society, New Orleans, Louisiana, November 1998. 138. Delayed Surgery for Traumatic Cataracts. American Academy of Ophthalmology, New Orleans, Louisiana, November 1998. 139. The Pathogeneses of Corneal Graft Failure. The American Academy of Ophthalmology and the American Association of Ophthalmic Pathologists on "Diseases of the Cornea." University of South Florida. November 1998. 140. Bausch and Lomb Ocular Surface Symposium: The Management of Herpes Simplex Keratitis. Tokyo, Japan. September 1998. 141. Ocular Surface Reconstruction. Juntendo University, Tokyo, Japan. September 1998. 142. Bausch and Lomb Ocular Surface Symposium: The Management of Herpes Simplex Keratitis. Osaka, Japan. September 1998. 143. Ocular Surface Reconstruction, Nippon University, Tokyo, Japan. September 1998. 144. Stem Cell Transplantation for Severe Corneal Surface Disease. Cleveland Clinic, Cleveland, Ohio, September 1998. 145. Surgical Management of Various Corneal External Diseases. Cleveland Clinic, Cleveland, Ohio, September 1998. 146. Clinical Challenges in the Management of Adenoviral Ocular Infections. 2nd International Conference on Ocular Infections. Munich, Germany. August 1998. 147. The Management of Herpes Simplex Keratitis. North Dakota Ophthalmological Society. Grand Forks, North Dakota. April 1998. 148. Herpes Simplex Keratitis. Greater New York Ophthalmology Clinical Lecture Series. New York City, New York. April 1998. 149. Keratolimbal Allograft for the Management of Servere Ocular Surface Disease. University of California. Davis Grand Rounds, Sacramento, California. January 1998. 150. Herpes Simplex Keratitis: Classification. University of California. Davis Grand Rounds, Sacramento, California. January 1998. 151. Management of Severe Ocular Surface Disease. Alta California Ophthalmology Society. Sacramento, California. January 1998. 152. Keratolimbal Allograft. Long Island Jewish Medical Center. Great Neck, New York. November 1997. 153. Corneal Transplant Rejection. Kansas City Society of Ophthalmology and Otolaryngology. Kansas City, Missouri. December 1997. 154. Treatment of Ocular Surface Disease. Kansas City Society of Ophthalmology and Otolaryngology. Kansas City, Missouri. December 1997. 155. Immunosuppressive Agents for the Treatment of Anterior Inflammatory Conditions. Kansas City Society of Ophthalmology and Otolaryngology. Kansas City, Missouri. December 1997. 156. Peripheral Corneal Thinning Disorders. Kansas City Society of Ophthalmology and Otolaryngology. Kansas City, Missouri. December 1997. 157. Treatment of Herpes Simplex Keratitis. Kansas City Society of Ophthalmology and Otolaryngology. Kansas City, Missouri. December 1997. 158. Classification of Herpes Simplex Keratitis. Kansas City Society of Ophthalmology and Otolaryngology. Kansas City, Missouri. December 1997. 159. Limbal Transplantation. Tokyo Dental College, Ichikawa General Hospital. Tokyo, Japan. October 1997. 160. Medical Standards for Safe Corneal Transplantation. The International Eye Bank Symposium. Tokyo, Japan. October 1997. 161. Herpes Simplex Keratitis. Kyoto Prefectural University of Medicine, Kyoto, Japan. October 1997. 162. Treatment of Viral Keratitis. The University of British Columbia. Vancouver, British Columbia, April 1997. 163. Epithelial Transplantation for the Management of Severe Ocular Surface Disease. The University of British Columbia. Vancouver, British Columbia April 1997. 164. Immunosuppressive Agents for Anterior Segment Inflammatory Disease. The University of British Columbia. Vancouver, British Columbia. April 1997. 165. Herpes Simplex Keratitis. Utah Ophthalmological Society. Salt Lake City, Utah. January 1997. 166. Epithelial Transplantation Procedures. Utah Ophthalmological. Salt Lake City, Utah. January 1997. 167. Gift of Life Organ, Tissue and Eye Donation: Update "97", United Hospital, St. Paul, Minneapolis. January 1997. 168. Topical Cyclosporine and Systemic Immunosuppression for Severe Anterior Segment Disease and High Risk Penetrating Keratoplasty. Wills Eye Hospital. Philadelphia, Pennsylvania. December 1996. 169. Epithelial Transplantation for Severe Ocular Surface Disease. Wills Eye Hospital. Philadelphia, Pennsylvania. December 1996. 170. Penetrating Keratoplasty and Intraocular Lens Exchange - The Case for Sutured Posterior Chamber Lenses. Wills Eye Hospital. Philadelphia, Pennsylvania. December 1996. 171. Unusual Clinical Presentations of Herpes Simples Keratitis. Biennial Cornea Conference. Wills Eye Hospital. Philadelphia, Pennsylvania. December 1996. 172. Immune Stromal Keratitis. New England Ophthalmological Society Meeting. Boston, Massachusetts. October 1996. 173. Peripheral Corneal Thinning Disorders. New England Ophthalmological Society Meeting. Boston, Massachusetts. October 1996. 174. Classification Epithelial Transplantation Procedures for the Management of Severe Ocular Surface Disease. Ocular Surface Anterior Workshop. Bascom Palmer Eye Institute. Miami. April 1996. 175. Epithelial Transplantation for the Management of Severe Ocular Surface Disease. World Congress of the Cornea IV. Orlando, Florida. April 1996. 176. Clinical Presentations of Herpes Simplex Keratitis. Mayo Clinic, Minneapolis. April 1995. 177. Management of Limbal Stem Cell Deficiency Syndromes. Michigan Ophthalmological Society. Detroit, Michigan. January 1995. 178. Management of Ocular Surface Disorders. Wisconsin and Upper Ophthalmological Society Annual Meeting. Wisconsin Dells, Wisconsin. September 1994. 179. Update on Transsclerally Sutured Posterior Chamber Lenses. Wisconsin and Upper Michigan Ophthalmological Society Annual Meeting. Wisconsin Dells, Wisconsin. September 1994. 180. Topical Cyclosporine A. Seoul National University. Seoul, Korea. September 1994. 181. Management of Herpes Simplex Keratitis. Ulsan University College of Medicine, Asian Medical Center, Department of Ophthalmology. Seoul, Korea. September 1994. 182. Corneal Epithelial Stem Cell Transplantation. Korean Ophthalmologic Society Annual Meeting. Seoul, Korea. September 1994. 183. Special Considerations in Cataract Surgery. Iowa Eye Annual Meeting, University of Iowa. Iowa City, Iowa. June 1994. 184. Conjunctival Stem Cell Transplantation. Iowa Eye Annual Meeting, University of Iowa. Iowa City, Iowa. June1994. 185. Clinical Presentations of Herpes Simplex Virus. Department of Ophthalmology, Cornell University. New York, New York. January 1994. 186. Management of Ocular Surface Disease. Catholic Medical Center. New York, New York. January 1994. 187. Clinical Presentations of Herpes Simplex Virus. Catholic Medical Center, New York, New York. January 1994. 188. Immunosuppressive Agents for Anterior Segment Inflammatory. Illinois Society of Ophthalmology and Otolaryngology. Galesburg, Illinois, October 1993. 189. Peripheral Corneal Thinning Disorders. Illinois Society of Ophthalmology and Otolaryngology. Galesburg, Illinois. October 1993. 190. Conjunctival Transplantation and Keratoepithelioplasty. Illinois Society of Ophthalmology and Otolaryngology. Galesburg, Illinois. October 1993. 191. Transsclerally Sutured Posterior Chamber Lens. Illinois Society of Ophthalmology and Otolaryngology. Galesburg, Illinois. October 1993. 192. Update on Management of Herpes Simplex Keratitis. Illinois Society of Ophthalmology and Otolaryngology. Galesburg, Illinois. October 1993. 193. Conjunctival Transplantation and Keratoepithelioplasty. St. Louis Ophthalmologic Society. St. Louis, Missouri. October 1993. 194. Diagnosis and Management of Corneal Disease. Washington University. St. Louis, Missouri. October 1993. 195. Herpes Simplex Keratitis: Clinical Spectrum and Management. Washington University. St. Louis, Missouri. October 1993. 196. Topical Cyclosporine: Safety and Efficacy. Washington University. St. Louis, Missouri. October 1993. 197. The Management of Chemical Burns. Cornea/Glaucoma Update Meeting, Indiana University. Indianapolis, Indiana. October 1993. 198. Indications and Techniques of Transsclerally Sutured Posterior Chamber Lens. Cornea/Glaucoma Update Meeting, Indiana University. Indianapolis, Indiana. October 1993. 199. Immunosuppressive Agents in Anterior Segment Inflammatory Disease. Cornea/Glaucoma Update Meeting, Indiana University. Indianapolis, Indiana, October 1993. 200. Conjunctival Transplantation and Keratoepithelioplasty. Annual Meeting of the Kentucky Ophthalmological Society. Louisville, Kentucky. September 1993. 201. Peripheral Corneal Thinning Disorders. Annual Meeting of the Kentucky Ophthalmological Society. Louisville, Kentucky. September 1993. 202. Management of Anterior Segment Inflammatory Disease. Meeting of the Kentucky Medical Association. Louisville, Kentucky. September 1993. 203. EBAA Medical Standards Overview. Eye Bank Association of America Annual Meeting. San Diego, California. June 1993. 204. Documenting the Medical Director's role in the Eye Bank, Eye Bank Association of America Annual Meeting. San Diego, California. June 1993. 205. Topical Cyclosporin A. Mayo Clinic. Rochester, Minneapolis. May 1993. 206. Clinical Findings in Herpes Simplex Keratitis. Minneapolis Ophthalmologic Society. Minneapolis, Minneapolis. November 1992. 207. Anterior Segment Reconstruction. Seventh Annual National Eye Trauma Symposium. Kansas City, Missouri. September 1992. 208. Management of the Lens in Anterior Segment Trauma. Seventh Annual National Eye Trauma Symposium. Kansas City, Missouri. September 1992. 209. Immunosuppressive Agents in Anterior Segment Inflammatory Disease. Case Western Reserve University. Cleveland, Ohio. April 1992. 210. Surgical Options for Secondary IOL/IOL Exchange. 1992 Cornea & External Disease Course. Miami, Florida. January 1992. 211. Corneal Graft Rejection and Management of PK Complications. 1992 Cornea and External Disease Course. Miami, Florida. 1992. 212. Transsclerally Sutured Posterior Chamber Lenses. Minneapolis Ophthalmological Society. Minneapolis, Minnesota. December 1991. 213. Immunosuppressive Agents for Anterior Segment Inflammatory Disease. University of Kentucky, Department of Ophthalmology. Lexington, Kentucky. November 1991. 214. Corneal Dystrophies. University of Kentucky, Department of Ophthalmology. Lexington, Kentucky. November 1991. 215. Topical Cyclosporine A. University of Kentucky, Department of Ophthalmology. Lexington, Kentucky. November 1991. 216. The Future of Topical Immunosuppressive in Ophthalmology. Washington State Medical Association Annual Meeting. Seattle, Washington. September 1991. 217. Clinical Results of Topical Cyclosporine in Anterior Segment Inflammatory Disease. Washington State MedicalAssociation Annual Meeting. Seattle. Washington. September 1991. 218. Immunosuppressive Agents for Anterior Segment Inflammatory Disease. Washington State Medical Association Annual Meeting. Seattle, Washington. September 1991. 219. Corneal Graft Rejection. Third Annual University of Illinois Chicago Eye Center Meeting, Chicago. Illinois. September 1991. 220. Blepharitis and Conjunctivitis. Third Annual University of Illinois Chicago Eye Center Meeting. Chicago, Illinois. September 1991. 221. Topical Cyclosporine. Third Annual University of Illinois Chicago Center Meeting. Chicago, Illinois. September 1991. 222. Transsclerally Sutured PCL. Cornea Conference, Department of Ophthalmology, Albany Medical College. Albany, New York. April 1991. 223. Management of Herpes Simplex Keratitis. Cornea Conference, Department of Ophthalmology, Albany Medical College. Albany, New York. April 1991. 224. Cyclosporine in the Treatment of Anterior Segment Inflammatory Disease. Indiana University. Indianapolis, Indiana. November 1990. 225. Management of Anterior Segment Inflammatory Disease. The Eleventh Annual Ophthalmology Clinical Conference. Morgantown, West Virginia. October 1990. 226. Corneal Complications of Cataract Surgery. Eleventh Annual Ophthalmology Clinical Conference. Morgantown, West Virginia, October 1990. 227. Suturing in the PC IOL: When, Where, How, and Why. Eleventh Annual Ophthalmology Clinical Conference. Morgantown, West Virginia. October 1990. 228. Corneal Transplant Rejection: Treatment and Prevention. University of Washington. Seattle, Washington. March 1990. 229. Diagnosis and Management of Corneal Dystrophies. University of Washington. Seattle, Washington. March 1990. 230. Management of Anterior Segment Inflammatory Disease. Sinai Hospital. Detroit, Michigan. November 1989. 231. Corneal Dystrophies. Sinai Hospital. Detroit, Michigan. November 1989. 232. Differential Diagnosis of Ocular Inflammation. Department of Medicine Grand Rounds, Abbott Northwestern Hospital. Minneapolis, MN. June 1989. 233. Suture Materials in Corneal Surgery. University of Kentucky. Lexington, KY, April 1989. 234. Immunology of Corneal Transplant Rejection. University of California-Davis. Sacramento, CA, July 1988. 235. Immunosuppressive Agents in Anterior Segment Inflammation. University of AlabamaBirmingham. June 1988. 236. Corneal Transplant Rejection. University of Alabama-Birmingham. June 1988. 237. Immunology of the Anterior Segment. University of Alabama-Birmingham. June 1988. 238. Trauma of the Anterior Segment. Mount Sinai Hospital. Minneapolis, Minnesota. May 1988. 239. Immunosuppressive Agents in Anterior Segment Disease. Minneapolis Ophthalmological Society. Minneapolis, Minnesota. April 1988. 240. Corneal Transplantation. Mount Sinai Hospital. Minneapolis, Minnesota. March 1988. 241. Treatment of Ocular Inflammatory Disease. Walter Reed Army Medical Center. Washington, D.C., December 1986. 242. Major Histocompatibility Antigens in Corneal Graft Rejection. National Eye Institute, National Institutes of Health. Bethesda, Maryland. April 1985. Named Lectureship (12) 1. SISCCO Medal Lecture. The Evolution of Lamellar Keratoplasty. Sienna, Italy. July 2013. 2. Glover-Lisman Lecture. New York University School of Medicine. New York, New York. May 2013. 3. David Paton Medal Lecture. Baylor Department of Ophthalmology Meeting. Waco, Texas. February 2013. 4. Gavin Herbert Lecture. Department of Ophthalmology, University of California, Irvine. October 2012. 5. Whitney Sampson Lecture. The Importance of the Ocular Surface. American Academy of Ophthalmology Annual Meeting. San Francisco, California. October 2009. 6. The Binkhorst Lecture and Medal. Corneal Transplantation: Beyond Penetrating Keratoplasty. American Society of Cataract and Refractive Surgeons Annual Meeting. Chicago, Illinois. April 2008. 7. The 2nd Annual John Aure Buesseler, MD Charles May Memorial Lecture. The Management of Severe Ocular Surface Disease. New York, New York. February 2005. 8. The 3rd Tom Casey Memorial Lecture. Techniques and Results in Corneal Grafting. International Refractive Meeting. Dublin, Ireland. October 2006. 9. The Richard L. Lindstrom CLAO Lecture. Limbal Stem Cell Transplantation. American Society of Cataract and Refractive Surgeons Meeting. San Diego, California. May 2004. 10. The 12th Annual George M. Kambara Distinguished Visiting Professorship Lecture. Ocular Surface Transplantation, Nashville, Tennessee. April 2002. 11. The Arthur Culler Memorial Lecture. Ohio State University, 44th Annual Postgraduate Symposium in Ophthalmology. Columbus, Ohio. March 2001. 12. Illinois Society for the Prevention of Blindness Lecture: Ocular Surface Transplantation. Chicago, Illinois. June2000. Books (5) 1. Holland EJ, Mannis MJ, and W. Barry Lee. Ocular Surface Disease: Cornea, Conjunctiva and Tear Film. Saunders Elsevier; 2013. 2. Krachmer JH, Mannis MJ, and Holland EJ, eds. Cornea: 3rd edition. Mosby Year Book Publishers; 2008 (In Press). 3. Krachmer JH, Mannis MJ and Holland EJ, eds. Cornea: 2nd Ed. Mosby Year Book Publishers; 2004. 4. Holland EJ and Mannis MJ, eds. Ocular Surface Disease: Medical and Surgical Management. Philadelphia: Springer-Verlag Publishers; November 2001. 5. Krachmer JH, Mannis MJ and Holland EJ, eds. Cornea. St. Louis: Mosby Year Book Publishers; 1997. Book Chapters (54) 1. Ponzin D, Ferrari S, Holland EJ, Biber JM. The Use of Allograft Corneas and Cells in Ophthalmic Surgery. In: The Warwick RM & Brubaker SB (eds). Tissue and Cell Clinical Use: An Essential Guide. Oxford, UK: Blackwell Publishing Ltd; 2012 (In Press). 2. Biber JM, Neff KD, Holland EJ, Mannis MJ. Corneal Transplantation in Ocular Surface Disease. In: Krachmer JH, Mannis MJ and Holland EJ, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 3. Djalilian AR, Kadakia A, Holland EJ. Postoperative Management of Ocular Surface Reconstruction. In: Krachmer JH, Mannis MJ and Holland EJ, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 4. Holland EJ, Schwartz GS, Daya SM, Djalilian AR. Surgical Techniques for Ocular Surface Reconstruction. In: Krachmer JH, Mannis MJ and Holland MJ, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 5. Schwartz GS, Holland EJ. Classification and Staging of Ocular Surface Disease. In: Krachmer JH, Mannis MJ, and EJ Holland, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 6. Nordlund ML, Neff KD, Holland EJ. Phacoemulsification and Endothelial Keratoplasty: The New Triple Procedure. In: Krachmer JH, Mannis MJ and Holland EJ, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 7. Nijm LM, Mannis MJ, Holland EJ. The Evolution of Contemporary Keratoplasty. In: Krachmer JH, Mannis MJ and Holland EJ, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 8. Holland EJ, Schwartz GS, Neff KD. Herpes Simplex Keratitis. In: Krachmer JH, Mannis MJ and Holland EJ, ed. Cornea: 3rd Ed. St Louis: Mosby Year Book Publishers; 2011. 9. Neff KD, Holland EJ. Ligneous Conjunctivitis. In: Krachmer JH, Mannis MJ and Holland EJ, ed. Cornea: 3rd Ed. St. Louis: Mosby Year Book Publishers; 2011. 10. Ponzin D, Ferrari S, Biber JM, Holland EJ. The Use of Allograft Corneas and Cells [and autograft where appropriate plus other allograft tissues (amnion) and cells and autologous tears in ophthalmic surgery]. In: Tissue and Cell Transplantation. Hoboken, New Jersey: Wiley Publisher; 2010 (In Press) 11. Skeens HM, Holland EJ. Minimally Invasive Corneal Surgery. In: Minimally Invasive Ophthalmic Surgery. Berlin Heidelberg: Springer-Verlag Publisher; 2010. 12. Djalilian AR, Nassiri N, Lee JA, Holland EJ. Immunosuppression in High-Risk Keratoplasty. In: Corneal Surgery: Theory, Technique and Tissue. London, England: Mosby Elsevier, Inc.; 2009. 13. Djalilian AR, Wadia HP, Balali S, Nassiri N, Holland EJ. Epithelial Transplantation for he Management of Severe Ocular Surface Disease. In: Corneal Surgery: Theory, Technique and Tissue. London, England: Mosby Elsevier, Inc.; 2009. 14. Holland EJ. AcrySof Toric IOL Technique: In: Chang DF, ed. Mastering the Refractive IOLs: The Art and Science. Thorofare, New Jersey: Slack Incorporated; 2008. 15. Tsai JH, Holland EJ. Suturing and Intraocular Lens. In Macsai MS, ed. Ophthalmic Microsurgical Suturing Techniques. Springer-Verlag, Berlin Heidelberg; 2007. 16. Djalilian AR, Holland EJ, Schwartz GS. Postoperative Management of Ocular Surface Reconstruction. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 17. Holland EJ, Schwartz GS, Nordlund ML. Surgical Techniques for Ocular Surface Reconstruction. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 18. Schwartz GS, Holland EJ. Classification and Staging of Ocular Surface Disease. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 19. Schwartz GS, Holland EJ. Management of Conjunctival and Corneal Neoplasia. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 20. Brilakis HS, Probst LE, Holland EJ. Penetrating Keratoplasty and Intraocular Lens Exchange. In: Krachmer JH, Mannis MJ, Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 21. Holland EJ, Brilakis HS, Schwartz GS. Herpes Simplex Keratitis. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 22. Brilakis HS, Holland EJ, Schwartz GS. Ligneous Conjunctivitis. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 23. Brilakis HS, Palmon FE, Webster GF, Holland EJ. Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 2nd Ed. St. Louis: Mosby Year Book Publishers; 2004. 24. Brilakis HS, Holland EJ. Microbial Keratitis after LASIK. In: Probst LE, ed. LASIK: Advances, Controversies, and Custom. Thorofare, New Jersey: Slack; 2004. 25. Brilakis HS, Holland EJ. Modern LASIK Results. In: Probst LE, ed. LASIK: Advances, Controversies, and Custom. Thorofare, New Jersey: Slack; 2004. 26. Kim JY, Djalilian AR, Schwartz GS, Holland EJ. Ocular Surface Reconstruction: Limbal stem cell transplantation. In: Foulks G, ed. Ophthalmology Clinics of North America – Cornea and External Disease. W.B. Philadelphia, Pennsylvania: Saunders Company a division of Elsevier; 2003. 27. Holland EJ, Mannis MJ, Schwartz GS. Developing a Logical Management Paradigm for the Clinical Management of Severe Ocular Surface Disease. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 28. Schwartz GS, Holland EJ. Etiology of Stem Cell Transplantation Failure. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 29. Djalilian AR, Nussenblatt RB, Holland EJ. Immunosuppressive Therapy in Ocular Surface Transplantation. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 30. Croasdale CR, Schwartz GS, Malling JV, Holland EJ. Keratolimbal Allograft: Recommendations for Tissue Procurement and Preparation by Eye Banks. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 31. Schwartz GS, Tsubota K, Tseng SCG, Mannis MJ, Holland EJ. Keratolimbal Allograft. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 32. Daya SM, Holland EJ, Mannis MJ. Living-Related Conjunctival Limbal Allograft. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 33. Croasdale CR, Holland EJ, Mannis MJ. Conjunctival Limbal Allograft. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 34. Schwartz GS, Gomes JAP, Holland EJ. Preoperative Staging of Disease Severity. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 35. Holland EJ, Schwartz GS. The Evolution and Classification of Ocular Surface Transplantation. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 36. Schwartz GS, Holland EJ. Iatrogenic Limbal Stem Cell Deficiency. In: Holland EJ and Mannis MJ, ed. Ocular Surface Disease: Medical and Surgical Management. New York: Springer-Verlag Publishers; 2001. 37. Croasdale C, Holland EJ. Epithelial Transplantation in the Management of Severe Ocular Surface Disease. In: Brightbill FS, ed. Corneal Surgery. St. Louis: Mosby Year Book Publishers; 3rd Edition, 1998. 38. Djalilian AR, Holland EJ. Immunosuppression in High Risk Keratoplasty. In: Brightbill FS, ed. Corneal Surgery. St. Louis: Mosby Year Book Publishers, 3rd Edition; 1998. 39. Palmon FE, Webster GF, Holland EJ. Erythema Multiforme, Stevens - Johnson syndrome and Toxic Epidermal Necrolysis. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 1st Ed. St. Louis: Mosby Year Book Publishers; 1997. 40. Schwartz GS, Holland EJ. Management of Conjunctival and Corneal Neoplasia. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 1st Ed. St. Louis: Mosby Year Book Publishers; 1997. 41. Probst LE, Holland EJ. Penetrating Keratoplasty and Intraocular Lens Exchange. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 1st Ed. St. Louis: Mosby Year Book Publishers; 1997. 42. Holland EJ. Herpes Simplex. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 1st Ed. St. Louis: Mosby Year Book Publishers; 1997. 43. Holland EJ. Ligneous Conjunctivitis. In: Krachmer JH, Mannis MJ, and Holland EJ, ed. Cornea: 1st Ed. St. Louis: Mosby Year Book Publishers; 1997. 44. Holland EJ, Hardten DR. Stevens-Johnson Syndrome in Pepose, J.S. In: Holland GN and Wilhelmus KR, ed. Ocular Infection and Immunity. St. Louis: Mosby Year Book Publishers; 1996. 45. Holland EJ, F.E. Palmon FE, Webster GF. Erythema Multiforme, Stevens - Johnson syndrome and Toxic Epidermal Necrolysis. In: Mannis MJ, Macsai MS, and Huntley AC, ed. Eye and Skin Disease. New York, New York: Lippincott-Raven Press; 1996. 46. Moyes AL, Hordinsky MK, Holland EJ. Ectodermal Dysplasia. In: Huntley AC, ed. Eye and Skin Disease. New York, New York: M.J. Mannis, M.S. Macsai, Lippincott-Raven Press; 1996. 47. Djalilian AR, Holland EJ. Local Immunosuppression: Corneal Transplantation. In: Gruber SA, ed. Local Immunosuppression of Organ Transplants. Austin, Texas: R.G. Landes Company; 1996. 48. Holland EJ, Grimmett MR, Lane SS. Penetrating Keratoplasty. In: Lindquist T, ed. Ophthalmic Surgery: A Loose-leaf Workbook and Update Service. Chicago: 5th Year Book Medical Publishers; 1995. 49. Holland EJ. Massive Ocular Surface Trauma. In: Roy F, ed. Masters of Ophthalmic Surgery. St. Louis: Mosby Year Book Publishers; 1995. 50. Holland EJ, Olsen TW. Immunosuppression. In: Brightbill FS, ed. High Risk Corneal Transplantation, in Corneal Surgery. St. Louis: C.V. Mosby Co.; 1992. 51. Van Meter WS, Holland EJ, DoughmanDJ. Corneal Edema. In: Schwab IR, ed. Duane's Clinical Ophthalmology. Philadelphia: J.B. Lippincott, Co.; 1992. 52. Lane SS, Holland EJ, Lindquist T. Epikeratophakia. In: Lindquist T, ed. Ophthalmic Surgery: A Looseleaf Workbook and Update Service. Chicago: 5th Year Book Medical Publishers; 1990. 53. Holland EJ, Lane SS, Lindstrom RL. Penetrating Keratoplasty. In: Lindquist T, ed. Ophthalmic Surgery: A Loose-leaf Workbook and Update Service. Chicago: 5th Year Book Medical Publishers; 1990. 54. Holland EJ. Reiter's Syndrome. In: Gold DH and Weingeist TA, ed. The Eye in Systemic Disease. Philadelphia: J.B. Lippincott, Co.; 1990: 56-58. Abstracts (138) 1. Darvish-Zargar M, Ang A, Chan C, Holland EJ. Outcomes of the Boston Type 1 Keratoprosthesis After Failed Ocular Surface Stem Cell Transplantation for the Management of Aniridic Keratopathy. Canadian Ophthalmologic Society Annual Meeting 2013. 2. Darvish-Zargar M, Ang A, Chan C, Holland EJ. Glaucoma and Associated Visual Outcomes with the Boston Type 1 Keratoprosthesis. American Society of Cataract and Refractive Surgery: Cornea Day. San Francisco, CA, April 2013. 3. Darvish-Zargar M, Ang A, Chan C, Holland EJ. Outcomes of Ocular Surface Stem Cell Transplantation and the Boston Type 1 Keratoprosthesis for the Management of Aniridic Keratopathy. Cornea Society/EBAA Fall Educational Symposium 2012. 4. Holland EJ, Ang AY. Assessment of Safety Outcomes and Contrast Sensitivity in Prospective Phase 2 U.S. Clinical Investigation of Angle - Supported Phakic IOLs. American Society of Cataract and Refractive Surgery Symposium. Chicago, Illinois, April 2012. 5. Ang AY, Chan CC, Hair D, Holland EJ. Boston Type 1 Keratoprosthesis Long-Term Outcomes and Complications: The Cincinnati Eye Institute Experience. American Society of Cataract and Refractive Surgery Symposium. Chicago, Illinois, April 2012. 6. Chan CC, Holland EJ. Severe Limbal Stem Cell Deficiency From Contact Lens Wear: Risk Factors and Patient Clinical Features. American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL and Refractive Surgery, Chicago, Illinois, April 23, 2012. 7. Donnenfeld ED, Holland EJ, Nichamin LD, Starr CE, Wallace RB, Conway TM and Hollander D. A Multicenter Evaluation of the Effects of Cataract Extraction and Limbal Relaxing Incisions on Corneal Sensation. American Academy of Ophthalmology Annual Meeting. Orlando, FL; 2011 8. Chan CC, Holland EJ. Boston Type 1 Keratoprosthesis Implantation in Eyes With Prior Ocular Surface Stem Cell Transplantation. American Academy of Ophthalmology Annual Meeting. Orlando, FL; 2011. 9. Bakhtiari P, Welder J, Chan CC, Cruz Jose De la,, Holland EJ, Djalilian AR. Surgical and Visual Outcomes of the Type 1 Boston Keratoprosthesis for the Management of Aniridic Fibrosis Syndrome in Congenital Aniridia Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Fort Lauderdale, Florida; May 2011. 10. Chan CC, Nordlund ML, Holland EJ. Risk Factors and Surgical Management of Boston Type 1 Keratoprosthesis-Related Tissue Melts, Leaks, and Extrusions. American Society of Cataract and Refractive Surgery Annual Meeting. San Diego, CA; 2011 11. Majmudar PA, Dubiner H, Epstein R, Ernest P, Greiner J, Hardten D, Holland E, Lane S, McDonald II JE, Silbert D. A Novel Thermal Pulsation Treatment for Obstructive Meibomian Gland Dysfunction: Applying Heat to the Inner Eyelid Surfaces: Poster. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Ft. Lauderdale, Florida; 2010. 12. Donnenfeld ED, Holland EJ, Solomon KD, Fiore J, Sandoval HP. Effect of Difluprednate 0.05% and Prednisolone Acetate 1% on Visual Acuity, Corneal Edema, and Patient Satisfaction Following Cataract Surgery. American Society of Cataract and Refractive Surgery Annual Meeting. Boston, Massachusetts; 2010. 13. Holland EJ, Biber JM. Clinical Outcomes of the AcrySof Phakic Angle-Supported IOL in a Phase 3 U.S. Clinical Trial: Poster. American Academy of Ophthalmology Annual Meeting. San Francisco, California; 2009. 14. Holland EJ. Prospective Study on Limbal Relaxing Incisions with the ORange Intraoperative Wavefront Aberrometer. European Society of Cataract and Refractive Surgeons Annual Meeting. Barcelona, Spain; 2009. 15. Neff KD, Holland EJ. Comparison of Central Corneal Graft Thickness and Visual Acuity Outcomes in Endothelial Keratoplasty. American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California; 2009. 16. Donnenfeld ED, Fiore J, Holland EJ, Prince J, Sandoval H, Solomon KD. The Effect of Preoperative and Postoperative Difluprednate and Prednisolone on Visual Acuity and Corneal Pachymetry. 2010. 17. Holland EJ, Assil KK, Donnenfeld ED, Lane SS, McDonald JE, Nichamin LD, Packer M. Advanced Astigmatism Management Using ORange Intraoperative Wavefront Aberrometer: Multicenter Study. American Society of Cataract and Refractive Surgery Annual Meeting. San Francisco, California; 2009. 18. Moglishetty G, Holland EJ. Comparison of Immunosuppression Related Toxicities and Complications in Ocular Surface Transplant and Renal Transplant Recipients: Implications for Composite Tissue Transplantation. XXII International Congress of the Transplantation Society Annual Meeting. Sydney, Australia; 2008. 19. Alloway RR, Skeens H, Cole L, Moglishetty G, Holland EJ, Vasilic D, Barker JH, RoyChaudhury P, Woodle ES. Ocular Surface Transplant Recipients Experience Fewer Immunosuppression Complications than Renal Transplant Recipients: Implications for Facial and Composite Tissue Transplantation. American Transplant Congress. San Francisco, California; 2007. 20. Alloway RR, Skeens H, Cole L, Moglishetty G, Holland EJ, Vasilic D, Barker JH, RoyChaudhury P, Woodle ES. Ocular Surface Transplant Recipients Experience Minimal Immunosuppression Complications: Implications for Composite Tissue Transplants. American Transplant Congress. San Francisco, California; 2007. 21. Donnenfeld ED, Sheppard JD, Holland ED, Slonim CB, Solomon R, Solomon KD, McDonald MB, Perry HD, Lane SS, Pflugfelder SC. Prospective, Multicenter, Randomized Controlled Study on the Effect of Loteprednol Etabonate on Initiating Therapy with Cyclosporine A: Poster. American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana; 2007. 22. Donnenfeld ED, Holland EJ, Perry H, Solomon R, Su M, Price F, Price M. The Effect of Intracameral Dexamethasone on Visual Outcomes in Descemet-Stripping Automated Endothelial Keratoplasty: Poster. American Academy of Ophthalmology Annual Meeting. New Orleans, Louisiana; 2007. 23. Holland EJ, Lane SS, Kim, T, Raizman M, Dunn S, Martin A, Jasheway D, Katz H, Faulkner R, Robertson S, Dahlin D. Human Cornea and Aqueous Humor Concentrations of Moxifloxacin and Gatifloxacin Following Topical Ocular Dosing with Vigamox Solution or Zymar: Poster. ARVO Annual Meeting. Ft. Lauderdale, Florida; 2006. 24. Donnenfeld ED, Holland EJ, Stewart R, Grillone LR. Topical Xibrom 0.09% Significantly and Rapidly Decreased Post-Cataract Surgery Inflammation and Reduced Ocular Pain: Poster. ARVO Annual Meeting. Ft. Lauderdale, Florida; 2005. 25. Shiffman ML, Donnenfeld ED, Holland EJ, Grillone LR. The Bromfenac Study Group: Investigation of Liver Toxicity Following Topical Treatment with Xibrom 0.1%, and NSAID for Post-cataract Surgery Inflammation. American Society of Cataract and Refractive Surgery Annual Meeting. Washington, D.C; 2005. 26. Holland EJ. Phase I Clinical Trial Results of the XACT Hydrophobic, High-Refractive-Index Acrylic IOL. American Society of Cataract and Refractive Surgery Annual Meeting. Washington, D.C; 2005. 27. Holland EJ. Techniques & Results of the Surgical Orientation of the Acrysof Toric IOL’s. American Society of Cataract and Refractive Surgery Annual Meeting. San Diego, California; 2004. 28. Freeman JM, Holland EJ. Medical Management of Epithelial Keratopathy Secondary to Iatrogenic Limbal Stem Cell Deficiency. American Society of Cataract and Refractive Surgery Annual Meeting. San Diego, California; 2004. 29. Nordlund ML, Derby E, Schwartz GS, Holland EJ. Success of Subsequent Penetrating Keratoplasty in Patients with Severe Ocular Surface Disease Treated with Stem Cell Transplantation: Poster. ARVO Invest Ophthalmol and Vis Sci. 2004. 30. Croasdale CR, Wise JP, Holland EJ. Human Monkeypox Ocular Infection: First Western Hemisphere Case Report. EBAA/Castroviejo Cornea Society Symposium. Anaheim, California; 2003. 31. Hicks C, Crawford G, Tan D, Grabner G, Dart J, Stulting D, Holland EJ. AlphaCor Outcome Data. EBAA/Castroviejo Cornea Society Symposium. Anaheim, California; 2003. 32. Brilakis HS, Holland EJ. Limbal Stem-Cell Deficiency as a Result of Contact Lens Induced Keratopathy. EBAA/Castroviejo Cornea Society Symposium. Anaheim, California; 2003. 33. Freeman JM, Schwartz, GS, Derby EA, Holland, EJ. Aniridia Fibrosis Syndrome. EBAA/Castroviejo Cornea Society Symposium. Anaheim, California; 2003. 34. Lass JH, Beck RW, Edwards SR, Gal RL, Ruedy KJ, Mannis MJ, Holland EJ, Rice CL. The Cornea Donor Study Investigator Group. Accuracy of Eye Bank Measurement of Donor Cornea Cell Density in the Cornea Donor Study. ARVO Invest Ophthalmol and Vis Sci. 2003. 35. Holland, EJ. Concentrations of Levofloxacin, Ofloxacin, and Ciprofloxacin in Aqueous Fluid and Corneal Tissue after Topical Ophthalmic Administration in Human Volunteers before Penetrating Keratoplasty. ARVO Invest Ophthalmol and Vis Sci. 2003. 36. Holland, EJ. Initial Clinical Results of the AcrySof Single-Piece Toric IOL. ASCRS. San Francisco, California; 2003. 37. Schwartz GS, Djalilian, AR, Nordlund, ML, Holland, EJ. Penetrating Keratoplasty after Keratolimbal Allograft. EBAA/Castroviejo Cornea Society Symposium. Orlando, Florida; 2002. 38. Nordlund, ML, Grimm SL, Holland EJ, and Lane SS. Late-Onset Diffuse Lamellar Keratitis Associated with Increased Intraocular Pressure. American Society of Cataract and Refractive Surgery Annual Meeting. Philadelphia, Pennsylvania; 2002. 39. Malecha MA, Holland EJ. Correction of Myopia and Astigmatism after Penetrating Keratoplasty with Laser in Situ Keratomileusis. The Castroviejo Cornea Society. Dallas, Texas; 2000. 40. Djalilian AR, Sanderson JP, Piracha AR, Holland EJ. The Use of Topical 0.5% Loteprednol Etabonate (Lotemax) in Corticosteroid induced Ocular Hypertension following Corneal Transplantation. The Castroviejo Cornea Society. Dallas, Texas; 2000. 41. Djalilian AR, Swanson PJ, Bradshaw JJ, Obritsch WF, Holland EJ. Genetic Transduction of Corneal Endothelial Cells Prior to Transplantation Using a Lentiviral Vector. ARVO Invest Ophthalmol and Vis Sci. 2000. 42. Stephens JJ, Holland EJ. Inflammatory Epithelial Basement Membrane Dystrophy. ARVO Invest Ophthalmol and Vis Sci. 2000. 43. Bradshaw JJ, Obritsch WF, Gregerson DS, Holland EJ. Stable Transduction of Mouse Corneas using a Novel Lentivral Based Vector. ARVO, Invest Ophthalmol and Vis Sci.1999. 44. Dvorak JA, Bradshaw JJ, Obritsch WF, Holland EJ. Direct Tracking of Epithelial Progenitor Cells and Migration in Vivo with a GFP Retroviral Vector. ARVO Invest Ophthalmol and Vis Sci. 1999. 45. Djalilian AR, Bradshaw JJ, Obritsch WF, Gregerson DS, Holland EJ. The Use of Donor Tissue from Transgenic Mice for the Study of corneal Epithelial Stem Cell Survival in Keratolimbal Transplantation. ARVO Invest Ophthalmol and Vis Sci. 1999. 46. Sinclair JM, Lushine MJ, Holland EJ, Wright MM. Combined Baerveldt Tube Implant and Keratolimbal Allograft for the Management of Glaucoma and Ocular Surface Disease. ARVO Invest Ophthalmol and Vis Sci. 1999. 47. Bradshaw JJ, Obritsch WF, Cho B, Gregerson DS, Holland EJ. Ex Vivo Transduction of Limbal Epithelial Progenitor Cells using a Retroviral Vector Leads to Extended Duration and Amplified in Vivo Expression. ARVO Invest Ophthalmol and Vis Sci. 1998. 48. Tomii S, Schwab IR, Mannis MJ, Hosotani H, Kinoshita JH, Lane JA, Sutphin JE, Cho B, Holland EJ. Evaluation of Human Corneal Epithelium in Diabetic Patients with Keratitis by in Vivo Confocal Microscopy. ARVO Invest Ophthalmol and Vis Sci.1998. 49. Cho B, Djalilian AR, Obritsch WF, Matteson DM, Chan CC, Holland EJ. Conjunctival Epithelial Cells Cultured on Human Amniotic Membrane Do Not Transdifferentiate into Corneal Epithelial Type Cells. ARVO Invest Ophthalmol and Vis Sci. 1998. 50. Olsen KE, Holland EJ. The Association between Ocular Cicatricial Pemphigoid and the Ocular Manifestations of Rheumatoid Arthritis. ARVO Invest Ophthalmol and Vis Sci. 1998. 51. Djalilian AR, Bagheri MM, Schwartz GS, Swanson L, Krachmer JH, Holland EJ. Keratolimbal Allograft (KLAL) for the Treatment of Limbal Stem Cell Deficiency. ARVO Invest Ophthalmol and Vis Sci.1998. 52. Lane SS, Holland EJ. Blunt Trauma Rupture of the Anterior Capsule - Management Strategies. American Society of Cataract and Refractive Surgery. San Diego, California; 1998. 53. Aronovich EL, Obritsch WF, Bradshaw JJ, Pan D, Manivel C, Holland EJ, Krachmer JH, Whitley CB. In Vivo Retrovirus Applicaton to the Cornea Results in Enzyme Replacement but not Long-term Gene Expression: Keystone Symposia on Molecular and Cellular Biology: Stem Cell Poster Session.1998. 54. Bradshaw JJ, Obritsch WF, Aronovich EL, Whitley CB, Holland EJ. Ex Vivo Transduction of Corneal Epithelial Progenitor Cells in a Leporine Model. Keystone Symposia on Molecular and Cellular Biology: Stem Cell Poster Session. 1998. 55. Djalilian AR, Aronovich EL, Bradshaw JJ, Cho B, Obritsch WF, Chan CC, Whitley CB, Krachmer JH, Holland EJ. Subconjunctival-Limbal Injection of Retrovirally Transduced Fibroblasts: A Possible Approach for Gene Delivery to the Cornea. ARVO Invest Ophthalmol and Vis Sci. 1997. 56. Nagy SS, Eiler DJ, Eggert JF, Sabir DI, Holland EJ: Workshop for Asssociated Disease in Patients with Scleritis. ARVO Invest Ophthalmol and Vis Sci. 1997. 57. Cho B, Djalilian AR, Obritsch WF, Holland EJ. Tandem Scanning Confocal Microscopic Analysis of Differences in Epithelial Healing Patterns of Limbal Stem Cell Deficiency and Simple Deepithelialization in Rabbits. ARVO Invest Ophthalmol and Vis Sci. 1997. 58. Cowden TP, Probst LE, Bryton KW, Heathcote G, Holland EJ. Perforation Pressures and Integrity of the Posterior Corneal Stroma Following Lasik. ARVO Invest Ophthalmol and Vis Sci. 1997. 59. Dana MR, Schaumberg DA, Myoes AL, Gomes JAP, Holland, EJ. Corneal Transplantation in Young Children with Peters' Anomaly and other Mesenchymal Dysgeneses. American Academy of Ophthalmology. Chicago, Illinois; 1996. 60. Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The Role of Topical Corticosteroids in Acanthamoeba Keratitis. ARVO Invest Ophthalmol and Vis Sci. 1996. 61. Obritsch WF, Bradshaw JJ, Mindrup EA, Gregerson DS, Holland EJ. Assessment of Oral Tolerance Induction in Graft Rejection. ARVO Invest Ophthalmol and Vis Sci. 1996. 62. Joplin AC, Lane SL, Mozayeni RM, Holland EJ. Delayed Surgery for the Management of Traumatic Cataract and Primary Capsular Rupture. ARVO Invest Ophthalmol and Vis Sci. April, 1996. 63. Whitley CB, Aronovich EL, Pfister DR, Obritsch WF, Pan D, Krachmer JH, Holland EJ. Topical Retrovirus Gene Therapy for Scheie Keratopathy. ARVO, Invest Ophthalmol and Vis Sci. 1996. 64. Bennett MD, Palay DA, Lynn MJ, Mozayeni RM, Gross SJ, Holland EJ. The Effect of Topical Cyclosporine A on Corneal Allograft Rejection after Pediatric Penetrating Keratoplasty. ARVO Invest Ophthalmol and Vis Sci.1996. 65. Pfister DR, Krachmer JH, Cameron JD, Doughman DJ, Holland EJ. Differentiating Squamous Cells from Melanocytes using Confocal Microscopy. ARVO Invest Ophthalmol and Vis Sci. 1996. 66. Harrison AH, Holland EJ. Acyclovir in Pediatric Herpes Simplex Virus (HSV) Keratitis. ARVO Invest Ophthalmol and Vis Sci. 1996. 67. Probst LE, Halfaker BA, Holland EJ. Quality of corneal donor tissue in the greater than 75 year age group. Eye Bank Association of America Annual Meeting. Atlanta, Georgia; 1995. 68. Anderson SO, Lane SS, Djalilian AR, Prebonich M, Holland EJ. Comparison of IOL Suturing Techniques for Transsclerally Sutured Posterior Chamber Intraocular Lenses with Penetrating Keratoplasty. Castroviejo Cornea Society Annual Meeting. Atlanta, Georgia; 1995. 69. Harrison AR, Chen K, Holland EJ. Etiologies of Interstitial Keratitis. Ocular Microbiology and Immunology Group Annual Meeting. Atlanta, Georgia; 1995. 70. Pfister DR, Cameron JD, Krachmer JH, Holland EJ. Confocal microscopy findings of acanthamoeba keratitis. Ocular Microbiology and Immunology Group Annual Meeting. Atlanta, Georgia; 1995. 71. Aronovich EL, Pfister DR, Holland EJ, Pan D, Obritsch WF, Sinclair JM, Bradshaw JJ, Anderson JA, Krachmer JH, Whitley CB. Scheie Keratopathy Associated with Mucopolysaccharidosis type I. The American Society of Human Genetics. Minneapolis, Minnesota; 1995. 72. Joplin AC, Michalova K, Obritsch WF, Bradshaw J, Pfister DR, Olsen TW, Mindrup EA, Holland EJ. Topical Rapamycin Inhibits Corneal Neovascularization in the Rate Penetrating Keratoplasty Model. ARVO Abstract Invest Ophthalmol and Vis Sci. 1995; V-36 N-4:1011. 73. Pfister DR, Holland EJ. Keratoepithelioplasty in the Management of Severe Ocular Surface Disease. ARVO Invest Ophthalmol and Vis Sci: Suppl. 1995; V-36 N-4:41. 74. Obritsch WF, Murali S, Dvorak JA, Mindrup EA, Holland EJ. CIS Urocanic Acid as an Immunosuppressant in the Rate Penetrating Keratoplasty Model. ARVO Invest Ophthalmol and Vis Sci: Suppl. 1995; V-36 N-4:1011. 75. Holland EJ, Probst LE, Scharf BH, Pfister DR. Intraocular Lens Implantation in Juvenile Rheumatoid Arthritis. ARVO Invest Ophthalmol and Vis Sci: Suppl. 1995; V-36 N-4:811. 76. Kanis AB, Mathers WD, Holland EJ, Rosenwasser GD, Rosa N, Kim W, Proud V, Lam B, Sheffield VC, Stone EM. Pooling Strategies and Haplotype Analysis of Autosomal Dominant Corneal Dystrophies - Studies in Lattice Granular and Avellino Dystrophies. ARVO Invest Ophthalmol and Vis. Sci: Suppl. 1995; V-36 N-4:771. 77. Palmon FE, Joplin AC, Dvorak JA, Obritsch WF, Chan C, Moyes AL, Holland EJ. Human Epithelial Cell Viability Following Keratoepithelioplasty in a Rabbit Model. ARVO Invest Ophthalmol. and Vis. Sci: Suppl. 1995; V-36 N-4:696. 78. Dana MR, Schaumberg DA, Moyes AL, Gomes JP, Holland EJ, Laibson PR, Sugar A, Sugar J. Outcome of Penetrating Keratoplasty for Ocular Trauma in Children - A Multicenter Experience. ARVO Invest Ophthalmol and Vis. Sci: Suppl. 1995; V-36 N-4:652. 79. Palmon FE, Tsai AW, Moyes AL, Egbert JE, Holland EJ. Lens Implantation without Primary Capsulotomy for Pediatric Cataracts. Ophthalmol: 101 Suppl. 1994. 80. George JE., Doughman DJ, Holland EJ. Comparison of the Triple Procedure and PK with Transsclerally Sutured Posterior Chamber Lenses. The Castroviejo Cornea Society Annual Meeting. San Francisco, CA; 1994. 81. Holland EJ, Scharf BH, Pederson JP. Gonioscopic Evaluation of Haptic Position in Transsclerally Fixated Posterior Chamber Lenses. The Castroviejo Cornea Society Annual Meeting. San Francisco, CA; 1994. 82. Palmon FE, Nelson JD, Holland EJ. Conjunctival Impression Cytology Following Keratoepithelioplasty for Severe Conjunctival and Corneal Scarring. ARVO 83. Invest Ophthalmol Vis Sci. 1994. 84. Olsen TW, Joplin AC, Anderson EE, Riedel P, Mindrup EA, Holland EJ. RS-61443 Prevents Corneal Allograft Rejection in the Orthotopic Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci 1994. 85. Joplin AC, Michalova K, Mindrup EA, Obritsch WF, Holland EJ. CTLA-4 lg Prolongs Corneal Allograft Survival in the Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1994. 86. Michalova K, Joplin AC, Mindrup EA, Obritsch WF, Holland EJ. Pretreatment with Cyclosporine A in Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1994. 87. Dana MR, Moyes AL, Gomes JA, Sugar J, Sugar A, Holland EJ. The Indications and Outcomes of Pediatric Keratoplasty. Ophthalmol: 102 Suppl. 1993. 88. O'Day DG., Murali S, Lane SS, Lindquist TD, Holland EJ. Primary and Secondary Transscleral Fixation of a Posterior Chamber Lens. Ophthalmol: 100 Suppl. 1993. 89. O'Day DG, Murali S, Mindrup EA, Olevsky OM, Ta CN, Hecht ML, Olsen TW, Obritsch WF, Holland EJ. Inhibition of Corneal Allograft Rejection by an Interleukin-2 Receptor Targeted Cytotoxin (DAB389IL-2). EBAA Annual Meeting. San Diego, CA; 1993. 90. Holland EJ, Hardten DR, Murali S, Lushine K, DeMartelaere S, Olevsky OM, Mindrup EA, Karlstad R, Chan CC: Effect of Topically Administered Platelet-Derived Growth Factor on Corneal Wound Strength in Penetrating Keratoplasty. ARVO Invest Ophthalmol Vis Sci. 1993. 91. Lee RM, Krachmer JH, Bucci FA, Nathenson AL, Janda AM, Harris J, Holland EJ. Mottled Cyan Opacification of the Posterior Cornea in Contact Lens Wearers. ARVO Invest Ophthalmol Vis Sci. 1993. 92. Murali S, Olsen TW, Gothard TW, Mindrup EA, Krachmer JH, Holland EJ. Misoprostol and Cyclosporine A Prolong Corneal Allograft Survival in the Orthotopic Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1993. 93. Olsen TW, Benegas NM, Morali S, Mindrup EA, Holland EJ: Low Dose Rapamycin and 15Deoxyspergualin Significantly Prolong Allograft Survival in the Orthotopic Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1993. 94. Daya SM, Park DH, Doughman DJ, Holland EJ. Factors Affecting Clinical Outcomes in Acanthamoeba Keratitis. Ocular Microbiology and Immunology Group Annual Meeting. Dallas, TX; 1992. 95. Olsen TW, Hardten DR, Meiusi RS, Holland EJ. Linear Endotheliitis. Ocular Microbiology and Immunology Group Annual Meeting. Dallas, TX; 1992. 96. Hardten DR, Gothard TW, Lane SS, Doughman DJ, Krachmer JH, Holland E.J.: New Clinical Findings in Brown-McLean Syndrome. Castroviejo Cornea Society Annual Meeting. Dallas, TX; 1992. 97. Kawashima H, Obritsch WF, Evangelista T, Ketcham JM, Holland, EJ, Gregerson, DS: Inhibitory Effects of Corneal Endothelial Cells on Autoimmune T Cells in Vitro. ARVO Invest Ophthalmol Vis Sci. 1992. 98. Lane SS, Spiegelman AV, Albert W, Lindquist T, VanMeter WS, Daya S, Joplin A., Holland EJ. Prospective Randomized Evaluation of Transscleral Sutured Posterior Chamber Lenses Verses Anterior Chamber Lenses with Penetrating Keratoplasty in the Absence of Capsular Support. ARVO Invest. Ophthalmol Vis Sci. 1992. 99. Olsen TW, Holland EJ, Ketchum J, Evangelista T, Mindrup E. Rapamycin Inhibits Corneal Allograft Neovascularization and Delays Rejection in the Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1992. 100. Holland EJ, Olsen TW, Evangelista T, Ketchum J, Mindrup E, Gruber SA. The Synergistic Action of Cyclosporin A and 15-Deoxyspergualin: Prolongation of Allograft Survival in the Rat Orthotopic Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1992. 101. Holland EJ, Ketcham JM, Evangelista A, Florine C, Purcell JJ, Krachmer J. Clinical Results of Topical Cyclosporine in Anterior Segment Inflammatory Disease. Castroviejo Society 17th Annual Meeting. Anaheim, California; 1991. 102. Daya SM, Holland EJ, Evangelista A, Ketcham JM, Lane SS, Doughman D. Penetrating Keratoplasty and Transscleral Fixation of Posterior Chamber Lens - The Minnesota Experience of 105 Patients. Castroviejo Society 17th Annual Meeting. Anaheim, California; 1991. 103. Lane SS, Cameron JD, Holland EJ, Mindrup E, McMichael W, Lindstrom RL. Fenestrated Intracorneal Lenses-Update and a Model for the Evaluation of Optical Resolution. ARVO Invest Ophthalmol Vis Sci. 1991. 104. Hardten DR, Holland EJ, Doughman DJ, Nelson JD. Transsclerally Sutured Posterior Chamber Lenses and Post-keratoplasty Astigmatism. ARVO Invest Ophthalmol Vis Sci. 1991. 105. Bergstrom LK, Holland EJ, Shapiro RS, Li Q, Chan CC. Interferon Interactions in the Regulation of MHC Class II Antigens in the Human Cornea. ARVO Invest Ophthalmol Vis Sci. 1991. 106. Holland EJ, Olsen TW, Sterrer J, McGehee R, Gruber SA. An Evaluation of Mizoribine and Cyclosporine in the Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1991. 107. Obritsch WF, Olsen TW, Bergstrom L, Holland EJ, McGehee R, Gregerson, DS. Inhibition of In Vitro T Cell Proliferative Responses by Corneal Endothelial Cells. ARVO Invest Ophthalmol Vis Sci. 1991. 108. Olsen TW, Holland EJ, Sterrer J, Holstein J, Gruber SA. Suppression of Graft Rejection Using Deoxyspergualin in the Allogeneic Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci. 1991. 109. Hardten DR, Doughman DJ, Holland EJ. Post-keratoplasty Astigmatism Following Transsclerally Sutured Posterior Chamber Lenses. Contact Lens Association of Ophthalmology, Annual Meeting. 1991. 110. Lubniewski AJ, Holland EJ, Doughman DJ. Transsclerally Sutured Posterior Chamber Lenses: Postoperative Management of the External Suture. The Castroviejo Cornea Society Annual Meeting. 1990. 111. Smith SG, Holland EJ, Peterson J. Peripheral Anterior Synechiae Formation with Anterior Chamber IOL's. The Castroviejo Cornea Society Annual Meeting. 1990. 112. Holland EJ, Stone EM, Folberg R, Dobler AA, Cameron JD, Doughman DJ. Avellino Corneal Dystrophy. The Castroviejo Cornea Society Annual Meeting. 1990. 113. VanMeter WS, Soloman K, Pearson A, Holland EJ. Posterior Chamber IOLs in the Absence of Capsular Support: An Anatomic Study of Transscleral Fixation. Ophthalmol: 97 Suppl. 1990. 114. Holland EJ, Alul IH, Epstein RJ, Meisler DM. Anterior Stromal Infiltrates in Acanthamoeba Keratitis. Ocular Microbiology and Immunology Group. 1990. 115. Doughman DJ, Hardten DR, Holland EJ, Gothard TW. Persistent Superficial Keratitis After Resolved Chlamydial Follicular Conjunctivitis. Ocular Microbiology and Immunology Group. 1990. 116. Brown JD, Holland EJ. Nd:YAG Laser Transscleral Cyclophotocoagulation in Post Penetrating Keratoplasty Glaucoma. Ophthalmol: 97 Suppl. 1990. 117. Holland EJ, Stone EM, Folberg R, Dobler AA, Cameron JD, Doughman DJ, Weismann BP. Avellino Corneal Dystrophy. Ophthalmol: 97 Suppl. 1990. 118. Summers CG, Holland EJ. Neodymium-YAG Pupilloplasty in Pediatric Aphakia. American Association for Pediatric Ophthalmology & Strabismus. 1990. 119. Pearlstein CS, Holland EJ, Tchah H, Crawford MA, Chan C. Suramin Toxicity in an Animal Model. ARVO Invest Ophthalmol Vis Sci. 1990; V-31 N-4: 542. 120. Mizener MW, Holland EJ, Mindrup EA, Bucci FA, Jr. The Effect of Corneal Storage Methods on Corneal Graft Rejection. ARVO Invest Ophthalmol Vis Sci. 1990; V-31 N-4: 269. 121. Lubniewski AJ, Holland EJ, Zabel RW, Maske R, Hill JC, Cameron JD. Posterior Infectious Crystalline Keratopathy. ARVO Invest Ophthalmol Vis Sci. 1990; V-31 N-4: 484. 122. Holland EJ, Tchah H, Dobler AA, Chan C, Mizener MW, Pearlstein ES, Zabel, RW. A Comparison of Suture Types in the Stimulation of Corneal Inflammation. ARVO Invest Ophthalmol Vis Sci. 1990; V-31N-4: 270. 123. Mahanti RL, Kobrin J, Holland EJ, Allen JS. Sympathetic Ophthalmia Following Post Cataract Surgery Bacterial Endophthalmitis. Ophthalmol: 96 Suppl. 1989; 128. 124. Duffey RJ, Agapitos PJ, Holland EJ, Lindstrom RL. Intraocular Mirror for Transscleral Fixation of Implants and Anterior Segment Reconstruction. Ophthalmol: 96 Suppl. 1989; 122. 125. Duffey RJ, Holland EJ and Lindstrom RL. Anatomical Study of Transsclerally Sutured Intraocular Lens Implantation. ARVO Invest Ophthalmol Vis Sci: 30 Suppl. 1989; 276. 126. Tchah H, Holland EJ, Pearlstein CS, Skelnik D, Chan C, Ni M, and Lindstrom RL. Modification of Corneal MHC Antigen Expression by Various Corneal Storage Methods. ARVO Invest Ophthalmol Vis Sci: 30 Suppl. 1989; 341. 127. Holland EJ, Tchah H, Skelnik D, Chan C, Ni M and Lindstrom RL. Human Corneal Endothelial Transplantation in the Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci: 30 Suppl. 1989; 338. 128. Holland EJ, Chan CC, Palestine AG, Rowsey JJ, Nussenblatt RB. Ligneous Conjunctivitis: Immunohistologic Findings and a New Treatment. OMIG. Las Vegas, NV. 1988. 129. Holland EJ, Chan C, Ni M, Palestine AG, Tchah H and Nussenblatt R.B. Kinetics of Corneal Transplant Rejection in the Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci: 29 Suppl. 1988; 228. 130. Bennett SR, Holland EJ, Brannian R, Osborne JC, Goeken J and Krachmer JH. The Risk of Cytomegalovirus Transmission by Penetrating Keratoplasty. 26th Annual Eye Bank Association of America Scientific Session. 1987. 131. Holland EJ, Palestine AG, Chan CC, Kuwabara T, Stein CA, LaRocca RV and Nussenblatt RB. Suramin Keratopathy. Ophthalmol: 94 Suppl. 1987; 128. 132. Holland EJ, Wetzig RP, Chan CC, Palestine AG and Nussenblatt RB. Clinical and Immunohistologic Studies of Corneal Rejection in the Rat Penetrating Keratoplasty Model. ARVO Invest Ophthalmol Vis Sci: 28 Suppl. 1987; 41. 133. Willis, RM, Folberg R, Krachmer JH and Holland EJ. The Treatment of Aqueous-Deficient Dry Eye with Removable Punctal Plugs: A Clinical and Impression-Cytologic Study. Ophthalmol: 93 Suppl. 1986; 114. 134. Mannis MJ, Zadnik K, Morrison T, Krachmer JH and Holland EJ. An analysis of Personality Trends in Keratoconus. ARVO Invest Ophthalmol Vis Sci: 27 Suppl. 1686; 66. 135. Holland EJ, Willis RM and Krachmer JH. Corneal thickness in Keratoconus. ARVO Invest Ophthalmol Vis Sci: 27 Suppl. 1986; 66. 136. Holland EJ, DeRuyter DN, Fertery II and Doughman DJ. The Effect of Organ Culture Cornea Preservation on Langerhans Cells. ARVO Invest Ophthalmol Vis Sci: 27 Suppl. 1985; 236. 137. Holland EJ, Pieh TH, Failinger MS, Penne RB, Cameron JD and Doughman DJ. Evaluation of the Major Histocompatibility Antigens in Corneal Allograft Rejection using a Heteroptopic Murine Model. ARVO. Invest Ophthalmol Vis Sci: 25Suppl. 1984; 229. 138. Holland EJ, Loren AB, O'Donnell KJ, Spence DJ, Tessler HH and Yokoyama MM. HLAB27, Klebsiella Pneumoniae and the Relation to Acute Anterior Uveitis. ARVO Invest Ophthalmol Vis Sci: 20 Suppl.1981; 110 Publications (191) 1. Bartley GB and Holland EJ. Antibiotic Resistance in Acute Postoperative Endophthalmitis. Ophthalmology. 2014; 121: 2. Dunn SP, Gal RL, Kollman C, Raghinaru D, Dontchev M, Blanton CL, Holland EJ, Lass JH, Kenyon KR, Mannis MJ, Main SI, Rapuano CJ, Stark WJ, Beck RW for the Cornea Donor Study Investigator Group. Corneal Graft Rejection Ten Years after Penetrating Keratoplasty in the Cornea Donor Study. Cornea 2014. (In Press) 3. Rajabi MT, Makateb A, Hashemi H, Holland EJ, Djalilian A, Nerad JA. Disaster in Cosmetic Surgery: Inadvertent Formalin Injection During Blepharoplasty. 4. Kim BY, Riaz KM, Bakhtiari P, Chan CC, Welder JC, Holland EJ, Basti S, and Djalilian AR. Medically Reversible Limbal Stem Cell Disease: Clinical Features and Management Strategies. Ophthalmology. 2014. “accepted for publication” 5. Verdier D, Sugar A, Baratz K, Beck RW, Dontchev M, Dunn S, Gal RL, Holland EJ, Kollman C, Lass JH, Mannis MJ, Penta J for the Cornea Donor Study Investigator Group. Corneal thickness as a predictor of corneal transplant outcome. Cornea 2013; 32: 729-736. PMC3840498. 6. Mannis MJ, Holland EJ, Gal RL, Dontchev M, Kollman C, Raghinaru D, Dunn S, Schultze, RL, Verdier DD, Lass JH, Raber, IM, Sugar, J, Gorovoy, MS, Sugar A, Stulting RD, Montoya MM, Penta JG, Benetz BA, Beck RW for the Cornea Donor Study Investigator Group. The Effect of Donor Age on Penetrating Keratoplasty for Endothelial Disease: Graft Survival after 10 Years in the Cornea Donor Study. Ophthalmology 2013; 120: 2419-2427. 7. Benetz BA, Lass JH, Gal RL, Sugar A, Menegay H, Dontchev M, Kollman C, Beck RW, Mannis MJ, Holland EJ, Gorovoy M, Hannush SB, Bokosky JE, Caudill JW; for the Cornea Donor Study Investigator Group. Endothelial morphometric measures to predict endothelial graft failure after penetrating keratoplasty. JAMA Ophthalmology. 2013 March; 131(5):601608. 8. Lass JH, Benetz BA, Gal RL, Kollman C, Raghinaru D, Dontchev M, Mannis MJ, Holland EJ, Chow C, McCoy K, Price FW, Sugar A, Verdier DD, Beck RW for the Cornea Donor Study Investigator Group. Donor age and factors related to endothelial cell loss ten years after penetrating keratoplasty: Specular Microscopy Ancillary Study. Ophthalmology 2013; 120: 2428-2435. 9. Chan CC, Holland EJ. Severe Limbal stem cell deficiency from contact lens wear: patient clinical features. Am J Ophthalmology. 2013 Mar; 155(3):544-549. 10. Ang AY, Chan CC, Biber JM, Holland EJ. Ocular surface stem cell transplantation rejection: Incidence, characteristics, and outcomes. Cornea. 2013 Mar; 32(2): 229-36. 11. Lane SS, Holland EJ. A Randomized, Mulitcenter, masked evaulation of 0.5% of Loteprednol Etabonate versus 1.0% Prednisolone Acetate for the treatment of inflammation following cataract surgery. The Journal of Cataract & Refractive Surgery. 2013 Feb; 39(2): 168-173. 12. Stulting RD, Sugar A, Beck RW, Belin M, Dontchev M, Feder RS, Gal RL, Holland EJ, Kollman C, Mannis MJ, Price F, Stark WJ, Verdier DD for the Cornea Donor Study Investigator Group. Effect of donor and recipient factors on corneal graft rejection. Cornea 2012; 31: 1141-1147. PMID: 22488114. 13. Sugar A, Montoya M, Beck RW, Cowden JW, Dontchev M, Gal RL, Kollman C, Malling J, Mannis MJ, Tennant B for the Cornea Donor Study Investigator Group. Impact of the Cornea Donor Study (CDS) on Acceptance of Corneas from Older Donors. Cornea 2012; 12: 1441-1445. PMID: 22262218. 14. Chan CC, Biber JM, Holland EJ. The Modified Cincinnati Procedure: Combined conjunctivallimbal autografts and keratolimbal allografts for severe ocular surface failure. Cornea. 2012 Nov; 31(11):1264-1272. 15. Chan CC, Holland EJ. Infectious keratitis in boston type 1 keratoprosthesis. Cornea. 2012 Oct; 31(10):1128-1134. 16. Ang AY, Chan CC, Nordlund ML, Holland EJ. Traumatic wound rupture after boston type 1 keratoprosthesis implantation. The Canadian Journal of Ophthalmology. 2012 Aug; 47(4): 376-379. 17. Chan CC, Yang P, Holland EJ. Descemetorrhexis in endothelial keratoplasty to avoid peripheral bullous keratopathy. Can J Ophthalmol. 2012 Jun; 47(3):243-245. 18. Holland EJ, Mogilishetty G, Skeens HK, Hair DB, Neff KD, Biber JM, Chan CC. Systemic immunosuppression in ocular surface stem cell transplantation:Results of a 10-year experience. Cornea. 2012 June; 31(6):655-661. 19. Tan D TH, Dart J, Holland EJ, Kinoshita S. Corneal Transplantation. Elsevier, The Lancet. 2012 May; 379(9827):1749-1761. 20. Bakhtiari P, Chan CC, Welder JD, Holland EJ, Djalilian AR. Surgical and visual outcomes of the type 1 boston keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. Am J Ophthalmology. 2012 May; 153(5):967-971. 21. Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald II JE, Silbert DI, Blackie CA, Stevens CA, Bedi R. A new system, the LipiFlow, for the treatment of Meibomian Gland Dysfunction (MGD). Cornea. 2012 April; 31(4):396-404. 22. Chan CC, Holland EJ. Infectious Endophthalmitis after Boston Type 1 Keratoprosthesis implantation. Cornea. 2012 April; 31(4):346-349. 23. Chan CC and Holland EJ. Management of astigmatism: Toric intraocular lenses. International Ophthalmology Clinic. 2012 Spring; 52 (2): 21-30. 24. Donnenfeld ED, Holland EJ, Solomon KD, Fiore J, Gobbo A, Prince J, Sandoval HP, Shull ER, Perry HD. A Multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus Prednisolone Acetate 1% in cataract surgery. Am J Ophthalmology. 2011 Oct; 152(4):609-617. 25. Lass JH, Beck RW, Benetz BA, Dontchev M, Gal RL, Holland EJ, Kollman C, Mannis MJ, Price F Jr, Raber I, Stark W, Stulting RD, Sugar A; for the Cornea Donor Study Investigator Group. Baseline factors related to endothelial cell loss following penetrating keratoplasty. Arch Ophthalmol. 2011 September; 129(9):1149-1154. 26. Biber JM, Skeens HM, Neff KD, Holland EJ. The Cincinnati Procedure: Technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea. 2011 Jul; 30(7):765-71. 27. Skeens HM, Brooks BP, Holland EJ. Congenital Aniridia variant: Minimally abnormal irides with severe limbal stem cell deficiency. Ophthalmology. 2011 July; 118(7):1260-1264. 28. Chan CC, Holland EJ, Sawyer WI, Neff KD, Petersen MR, Riemann CD. Boston Type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in pre-phthisical eyes. Cornea. 2011 Jun; 30:1105-1109. 29. Daya SM, Chan CC, Holland EJ; On Behalf of the Members of The Cornea Society Ocular Surface Procedures Nomenclature Committee. Cornea Society nomenclature for ocular surface rehabilitative procedures. Cornea. 2011 Jun; 30:1115-1119. 30. Chan CC, Holland EJ. Cataract surgery after keratolimbal allograft surgery in patients with congenital Aniridia. Journal of Cataract and Refractive Surgery. 2011 Apr; 37(4):786-787. 31. Neff KD, Biber JM, Holland EJ. Comparison of central corneal graft thickness to visual acuity outcomes in endothelial keratoplasty. Cornea. 2011 Apr; 30(4):388-391. 32. Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Non-obvious Obstructive Meibomian Gland Dysfunction (NOGMD). Cornea. 2010 Dec; 29(12):1333-1345 33. Holland EJ, Lane SS, Horn JD, Ernest P, Arleo R, Miller KM. AcrySof Toric intraocular lens in subjects with cataracts and corneal astigmatism: A randomized, subject-masked, parallelgroup, 1-year study. Ophthalmology. 2010 Nov; 117(11):2104-2111. 34. Djalilian AR, Mali JO, Holland EJ. The use of argon laser punctal stenosis in patients with contact lens-induced dry eyes. Eye Contact Lanes. 2010 May; 36(3):144-148. 35. Comstock TL, Holland EJ. Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens. Expert Opin Pharmacother. 2010 Apr; 11(5): 843852. 36. Djalilian AR, Kim JY, Saeed HN, Holland EJ, Chan CC. Histopathology and treatment of corneal disease in keratitis, ichthyosis and Deafness (KID) Syndrome. Eye. 2010 April; 24(4):738-740. 37. Skeens HM, Holland EJ. Large-diameter penetrating keratoplasty: Indications and outcomes. Cornea. 2010 Mar; 29(3):296-301. 38. The Cornea Donor Study Investigator Group. Lass JH, Sugar A, Benetz BA, Beck RW, Dontchev M, Gal RL, Kollman C, Gross R, Heck E, Holland EJ, Mannis MJ, Raber I, Start WJ, Stulting RD. Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty. Archives of Ophthalmology. 2010 Jan; 128(1):63-69. 39. Holland EJ. Aspheric Toric Intraocular Lenses for Cataractous Eyes: Correction of corneal cylinder and spherical aberration. Expert Review of Ophthalmology. 2010; 117(11):21042111. 40. Biber JM, Holland EJ, Neff KD. Management of ocular stem cell disease. International Ophthalmology Clinics. 2010;50(3):25-34. 41. Holland EJ, Djalilian AR, Sanderson JP. Attenuation of ocular hypertension with the use of topical Loteprednol Etabonate 0.5% in steroid responders after corneal transplantation. Cornea. 2009 Dec; 28(10):1139-1143. 42. The Cornea Donor Study Investigator Group. Sugar J, Montoya M, Dontchev M, Tanner JP, Beck RW, Gal RL, Gallagher S, Gaster R, Heck E, Holland EJ, Kollman C, Malling J, Mannis MJ, Woody J. Donor risk factors for graft failure in the Cornea Donor Study. Cornea. 2009 Oct; 28:981-985. 43. The Cornea Donor Study Investigator Group. Sugar A, Tanner JP, Dontchev M, Tennant B, Schultze RL, Dunn SP, Lindquist TD, Gal RL, Beck RW, Kollman C, Mannis MJ, Holland EJ. Recipient risk factors for graft failure in the Cornea Donor Study. Ophthalmology. 2009 Jun; 116(6):1023-1028. 44. The Cornea Donor Study Investigator Group. Dunn SP, Stark WJ, Stulting RD, Lass JH, Sugar A, Pavilack MA, Smith PW, Tanner JP, Dontchev M, Gal RL, Beck RW, Kollman C, Mannis MJ, Holland EJ. The Effect of ABO blood incompatibility on corneal transplant failure in conditions with low-risk of graft rejection. Am J Ophthal. 2009 Mar; 147(3):432-438. 45. Lindstrom RL, Holland EJ, Lane SS. Fluoroquinolones and postoperative endophthalmitis. J Cataract Refract Surg. 2009 Feb; 35(2):206-207. 46. Powe A, Gal RL, Beck RW, Mannis MJ, Holland EJ. The Cornea Donor Study Investigator Group. The Cornea Donor Study. Vision Pan-America. 2009; 8:9-12. 47. Bartlett JD, Holland EJ, Usner DW, Paterno MR, Comstock TL. Tolerability of Loteprednol/Tobramycin versus Dexamethasone/Tobramycin in Healthy Volunteers: Results of a 4-week, randomized, double-asked, parallel-group Study. Curr Med Res Opin. 2008 Aug; 24(8):2219-2227. 48. Shinozaki N, Holland EJ, Kearney J, Kurz J, Chapman J. Global coding system for human cells and tissues for transplantation. Transplantation. 2008 Jul; 86(1):181. 49. Cornea Donor Study Investigator Group, Lass JH, Gal RL, Dontchev M, Beck RW, Kollman C, Dunn SP, Heck E, Holland EJ, Mannis MJ, et al. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology. 2008 Apr; 115(4):627-632. 50. Lindstrom R, Holland EJ, Lane S, Raizman M, Reilly C. Double-masked comparison of Ketorolac Tromethamine 0.4% versus Nepafenac Sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Cornea. 2008 Apr; 27(3):385387. 51. Cornea Donor Study Investigator Group, Gal RL, Dontchev M, Beck RW, Mannis MJ, Holland EJ, Kollman C, et al. The Effect of donor age on corneal transplantation outcome results of the Cornea Donor Study. Ophthalmology. 2008 Apr; 115(4):620-626. 52. Holland EJ, Lane SS, Kim T, Raizman M, Dunn S. Ocular penetration and Pharmacokinetics of Topical Gatifloxacin 0.3% and Moxifloxacin 0.5% Ophthalmic solutions after keratoplasty. Cornea. 2008 Apr; 27(3):314-319. 53. Holland EJ, Bartlett JD, Paterno MR, Usner DW, Comstock TL. Effects of Loteprednol/Tobramycin versus Dexamethasone/Tobramycin on intraocular pressure in healthy volunteers. Cornea. 2008 Apr; 27(1):50-55. 54. Holland EJ, McCarthy M, Holland S. The ocular penetration of Levofloxacin 1.5% and Gatifloxacin 0.3% Ophthalmic solutions in subjects undergoing corneal transplant surgery. Curr Med Res Opin. 2007 Dec; 23(12):2955-2960. 55. Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR. Bromfenac ophthalmic solution 0.09% (Xibrom) study group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology. 2007 Sep; 114(9):1653-1662. 56. Donnenfeld ED, Holland EJ, Durrie DS, Raziman MB. Double-masked study of the effects of Nepafenac 0.1% and Ketorolac 0.4% on cornea epithelial wound healing and pain after photorefractive keratectomy. Adv Ther. 2007 Jul-Aug; 24(4):852-862. 57. Shah M, Holland EJ, Chan CC. Resolution of autoimmune polyglandular syndromeassociated keratopathy with keratolimbal stem cell transplantation: case report and historical literature review. Cornea. 2007 June; 26(5):632-635. 58. Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract. Surg. 2007 Jan; 33(1):53-58. 59. Hicks CR, Crawford GJ, Dart JK, Grabner G, Holland EJ, Stulting RD, Tan DT, Bulsara M. AlphaCor: clinical outcomes. Cornea. 2006 Oct; 25(9):1034-1042. 60. Tsai JH, Derby E, Holland EJ, Khatana AK. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea. 2006 Jun; 25(5):530-532. 61. Cornea Donor Study Group. Clinical profile and early surgical complications in the cornea donor study. Cornea. 2006 Feb; 25(2):164-170. 62. Brilakis HS, Holland EJ. Anterior stromal puncture in the treatment of loose epithelium after LASIK. J Refract Surg. 2006 Jan-Feb; 22(1):103-105. 63. Benetz BA, Gal RL, Ruedy KJ, Rice C, Beck RW, Lass JL for The Cornea Donor Study Group. . Specular microscopy ancillary study methods for donor endothelial cell density determination of cornea donor study images (SMAS). Current Eye Research. 2006; 31:319327. 64. Tsai JH, Freeman JM, Chan CC, Schwartz GS, Derby EA, Petersen MR, Holland EJ. A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia. Am J Ophthalmol. 2005 Dec; 140(6):1075-1079. 65. Holland EJ. Ectasia following laser in situ keratomileusis. J Cataract Refract Surg. 2005 Nov; 31(11):2034. 66. Donnenfeld ED, Kim T, Holland EJ, Azar DT, Palmon FR, Rubenstein JB, Daya S, Yoo SH. American Society of Cataract and Refractive Surgery Cornea Clinical Committee. ASCRS White Paper: management of infectious keratitis following laser in situ keratomileusis. J Cataract Refract Surg. 2005 Oct; 31(10):2008-2011. 67. McCulley TJ, Mayer K, Dahr SS, Simpson J, and Holland EJ. Aniridia and optic nerve hypoplasia. Eye. 2005 Jul; 19(7):762-764. 68. Cornea Donor Study Group. Sugar A, Gal RL, Beck W, Ruedy KJ, Blanton CL, Feder RS, Hardten DR, Holland EJ, Lass JH, Mannis MJ, O’Keefe MB. Baseline donor characteristics in the cornea donor study. Cornea. 2005 May; V-24 N-4: 389-396. 69. Lass JH, Gal RL, Ruedy KJ, Benetz BA, Beck RW, Baratz KH, Holland EJ, Kalajian A, Kollman C, Manning FJ, Mannis MJ, McCoy K, Montoya M, Stulting D, Xing D. Cornea Donor Study Group: An evaluation of image quality and accuracy of eye bank measurement of donor cornea endothelial cell density in the specular microscopy ancillary study. Ophthalmology. 2005 Mar; 112(3):431-440. 70. Djalilian AR, Mahesh SP, Koch CA, Nussenblatt RB, Shen D, Zhuang Z, Holland EJ, Chan CC. Survival of donor epithelial cells after limbal stem cell transplantation. Invest Ophthalmol Vis Sci. 2005 Mar; 46(3):803-807. 71. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate pphthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004 Sep; 138(3):444-457. 72. Brilakis HS, Nordlund ML, Holland EJ. Recurrence of Fuchs’ marginal keratitis within a lamellar graft. Cornea. 2004 Aug; 23(6):639-640. 73. Shimazaki J, Shinozaki N, Shimmura S, Holland EJ, Tsubota K. Efficacy and safety of international donor sharing: A single-center, case-controlled study on corneal transplantation. Transplantation. 2004 Jul; 78(2):216-220. 74. Holland EJ, Schwartz GS. The Paton Lecture: Ocular surface transplantation:10 years’ experience. Cornea. 2004 Jul; 23(5):425-431. 75. Nordlund ML, Holland EJ, Kersten RC. Ocular surface reconstruction in a patient with complete ankyloblepharon resulting from Stevens-Johnson syndrome. Arch Ophthalmol. 2004 Jun; 122(6):934-935. 76. Nordlund ML, Holland EJ, Lane S, Grimm S. Pressure-induced interface keratitis: A late complication following LASIK. Cornea. 2004 Apr; 24(4):505. 77. Healey D, Nordlund ML, Holland EJ. Concentrations of Levofloxacin, Ofloxacin, and Ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea. 2004 Apr; 23(3):255-263. 78. Brilakis HS, Holland EJ. Diode-laser-induced cataract and iris atrophy as a complication of eyelid hair removal. Am J Ophthalmol. 2004 Apr; 137(4):762-763. 79. Solomon R, Donnenfeld ED, Azar DT, Holland EJ, Palmon FR, Pflugfelder SC, Rubenstein JB. Infectious keratitis after laser in situ keratomileusis: results of an ASCRS survey. J Cataract Refract Surg. 2003 Oct; 29(10):2001-2006. 80. Djalilian AR, Holland EJ, Schwartz GS. Limbal stem cell deficiency. Ophthalmology. 2003 Oct; 110(10): 2071. 81. Mendes F, Schaumberg DA, Navon S, Steinert R, Sugar J, Holland EJ, Dana MR. Assessment of visual function after corneal transplantation: The quality of life and psychometric assessment after corneal transplantation (Q-PACT) study. Am J Ophthal. 2003 Jun; 135(6):785-793. 82. Mayer KL, Nordlund ML, Schwartz GS, Holland EJ. Keratopathy in congenital aniridia. The Ocular Surface. 2003 Apr; 1(2):74-79. 83. Kim JY, Djalilian AR, Schwartz GS, Holland EJ. Ocular surface reconstruction: limbal stem cell transplantation. Ophthalmology Clinics of North America. 2003 Mar; 16(1):67-77. 84. Souza PM, Holland EJ, Huang AJ. Bilateral herpetic keratoconjunctivitis. Ophthalmology. 2003 Mar; 110(3):493-496. 85. Holland EJ, Djalilian AR, Schwartz GS: Management of aniridic keratopathy with keratolimbal allograft: A limbal stem cell transplantation technique. Ophthalmology. 2003 Jan; 110(1):125-130. 86. Malecha MA, Holland EJ. Peripheral keratitis associated with chronic myelomonocytic leukemia. Cornea. 2002 Oct; 21(7):723-724. 87. Malecha MA, Holland EJ. Correction of myopia and astigmatism after penetrating keratoplasty with laser in situ keratomileusis. Cornea. 2002 Aug; 21(6): 564-569. 88. Tsubota K, Shimmura S, Shinozaki N, Holland EJ, Shimazaki J. Clinical application of living-related conjunctival-limbal allograft. Am J Ophthalmol. 2002 Jan; 133(1):134-135. 89. Schwartz GS, Holland EJ. Iatrogenic limbal stem cell deficiency: When glaucoma management contributes to corneal disease. J Glaucoma. 2001 Dec; 10(6):443-445. 90. Nordlund ML, Holland EJ, Osher RH. Consultation section: Cataract surgical problem. Journal of Cataract and Refractive Surgery. 2001; 27:805-810. 91. Holland EJ, Schwartz GS. Changing Concepts in the management of severe ocular surface disease over twenty-five years. Cornea. 2000 Sep; 19(5):688-698. 92. Schwartz GS, Holland EJ. Oral acyclovir for the management of herpes simplex virus keratitis in children. Ophthalmology. 2000 Feb; 107(2):278-282. 93. Holland EJ. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology. 2000; 108(1):133-134. 94. Holland EJ. Discussion of diffuse lamellar keratitis related to endotoxins released from sterilizer reservoir biofilms. Ophthalmology. 2000; 107(7):1233-1234. 95. Grimmet MR, Holland EJ. Small clear-zone radial keratotomy. Ophthalmology.1999 Oct; 106(10):1857-1858. 96. Beck RW, Gal RL, Mannis MJ, Holland EJ et al. Is donor age an important determinant of graft survival? Cornea. 1999 Sep; 18(5):503-510. 97. Holland EJ, Schwartz GS. Epithelial stem cell transplantation for severe ocular-surface disease. N. Engl. J. Med. 1999 Jun; 340(22):1752-1753. 98. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea. 1999 Mar; 18(2):144-154. 99. Cho BJ, Djalilian AR, Obritsch WF, Matteson DM, Chan CC, Holland EJ. Conjunctival epithelial cells cultured on human amniotic membrane fail to tran differentiate into corneal epithelial type cells. Cornea. 1999 Mar. 18(2):216-224. 100.Schaumberg DA, Moyes AL, Gomes JA, Dana MR. Multicenter Pediatric Keratoplasty Study Group. Corneal transplantation in young children with congenital hereditary endothelial dystrophy. Am J Ophthalmol. 1999; 124:373-378. 101. Sinclair JM, Lushine MJ, Holland EJ, Wright MM. Combined baerveldt tube implant and keratolimbal allograft for the management of glaucoma and ocular surface disease. Investigative Ophthalmology and Visual Science. 1999; 40: 274. 102. Miller MR, Holland EJ. Cataract surgical problem. Consultation section report, J Cataract Refract Surg. 1999; V-25. 103. Bradshaw JJ, Obritsch WF, Cho BJ, Gregerson DS, Holland EJ. Ex Vivo transduction of corneal epithelial progenitor cells using a retroviral vector. IOVS. 1999 Jan; 40(1):230-235. 104. Croasdale CR, Schwartz GS, Malling JV, Holland EJ. Keratolimbal allograftrecommendations for tissue procurement and preparation by eye banks and standard surgical technique. Cornea. 1999 Jan; 18(1):52-58. 105. Cho BJ, Holland EJ. In vivo tandem scanning confocal microscopy in acanthamoeba keratitis. Korean J Ophthalmology. 1998 Dec; 12(2):112-117. 106. Olsen KE, Holland EJ. The association between ocular cicatricial pemphigoid and rheumatoid arthritis. Cornea. 1998 Sep; 17(5):504-507. 107. Djalilian AR, Holland EJ. Long-term results of transsclerally sutured posterior chamber lenses in penetrating keratoplasty. Cornea. 1998 Jul; 17(4):359-364. 108. Cho B., Gross, SJ, Pfister, DR, Holland EJ. In vivo confocal microscopic analysis of corneal allograft rejection in rabbits. Cornea. 1998 Jul; 17(4):417-422. 109. Schwartz GS, Harrison AR, Holland EJ. Etiology of immune stromal (interstitial) keratitis. Cornea. 1998 May; 17(3):278-281. 110. Cho B, Djalilian AR, Obritsch WF, Holland EJ. Tandem scanning confocal microscopic analysis of differences in epithelial healing patterns of limbal stem cell deficiency and simple reepithelialization in rabbits. Cornea.1998 Jan; 17(1):68-73. 111. Schwartz GS, Holland EJ. Iatrogenic limbal stem cell deficiency. Cornea. 1998 Jan; 17(1):31-37. 112. Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Peter J, Savir H, Holland EJ. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: A Multicenter Experience. Ophthalmology. 1997 Dec; 104(12):2085-2093. 113. Probst LE, Halfaker BA, Holland EJ. Quality of corneal donor tissue in the greater than 75 year age group. Cornea. 1997 Sep; 16(5):507-511. 114. Probst LE, Holland EJ. Anterior subtotal vitrectomy with fibre-optic illumination. Can J Ophthalmology. 1997 Jun; 32(4):254-255. 115. Djalilian AR, George JE, Doughman DJ, Holland EJ. Comparison between the refractive results of combined penetrating keratoplasty/transsclerally suture posterior chamber lens implantation and the triple procedure. Cornea.1997 May; 16(3):319-321. 116. Park DH, Palay DA, Daya, SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the management of acanthamoeba keratitis. Cornea. 1997 May; 16(3):277-283. 117. Holland, EJ, Djalilian AR, Pederson J. Gonioscopic evaluation of haptic position in transsclerally sutured posterior chamber lenses. Am J Ophthalmol. 1997 Mar; 123: 411-413. 118. Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the management of acanthamoeba keratitis. Clinical trial Journal Article. Multi-center Study. Cornea. 1997; 16(3): 277-283. 119. Schwartz GS, Holland EJ. Iatrogenic limbal stem cell deficiency. Trans AM Ophthalmol Soc. 1997; V-XCV: 95-110. 120. Dana MR, Schaumberg DA, Moyes AL. Gomes JAP Study Group. Corneal transplantation in children with peters anomaly and mesenchymal dysgeneses. Ophthalmology. 1997; 10: 1580-1586. 121. Grimmett MR, Holland EJ. Complications of small clear-zone RK (Letter). Ophthalmology.1997; 104: 735. 122. Probst LE, Peikoff HD, Pfister DR, Sabir DI, Holland EJ. Photothrombic occlusion of corneal neovascularization using indocyanine green and the diode laser. Ophthalmic Practice. 1997; 15: 2. 123. Holland EJ and Schwartz GS. The evolution of transplantation for severe ocular surface disease and a proposed classification system. Cornea. 1996 Nov; 15(6):549-556. 124. Grimmett MR, Holland EJ. Complications of small clear-zone radial keratotomy. Ophthalmology. 1996 Sep; 103(9):1348-1356. 125. Puk DE, Probst LE, Holland EJ. Recurrent erosion following photorefractive keratectomy. Cornea. 1996 Sep; 15(5):541-542. 126. Probst LE, Holland EJ. Intraocular lens implantation in patients with juvenile rheumatoid arthritis. Am J Ophthalmol. 1996 Aug; 122(2):161-170. 127. Pfister DR, Cameron JD, Krachmer JH, Holland EJ. Confocal microscopy findings of acanthamoeba keratitis. Am J Ophthalmol. 1996 Feb; 121(2):119-128. 128. Olsen TW, Gothard TW, Holland EJ. Misoprostol with cyclosporine A prolongs corneal allograft survival in an animal model. Cornea. 1996 Jan; 15(1):76-81. 129. Puk DE, Ketcham JM, Probst LE, Cameron JD, Holland EJ. Conjunctival malignant melanoma. Arch Ophthalmol. 1996 Jan; 114: 100-101. 130. Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc. 1996; V-XCIV: 94:677-743. 131. Shah GK, Pfister DR, Probst LE, Ferrieri P, Holland EJ. Diagnosis of microspoidial 1 keratitis by confocal microscopy and the chromatrope stain. Am J Ophthalmol.1996; 121:89-91. 132. Dana MR, Schaumberg DA, Moyes AL, Gomes JA, Laibson PR, Holland EJ, Sugar A, Sugar J. Outcome of penetrating keratoplasty after ocular trauma in children. Arch Ophthalmology. 1995 Dec; 113(12):1503-1507. 133. Moyes AL, Holland EJ, Palmon FE, Dvorak JA, Doughman DJ. Tissue utilization at the Minnesota Lions' Eye Bank. Cornea.1995 Nov; 14(6):571-577. 134. Shah GK, Cantrill HL, Holland EJ. Vortex keratopathy associated with atovaquone. Am J Ophthalmol.1995 Nov; 120:669-671. 135. Schwartz GS, Holland EJ. Induction of ligneous conjunctivitis by conjunctival surgery. Am J Ophthalmol.1995 Aug; 120(2):253-254. 136. Dana MR, Moyes AL, Gomes J.A., Rosheim KM, Schaumberg OD, Laibson PR, Holland EJ, Sugar A, Sugar J. The indications for and outcome in pediatric keratoplasty. A Multicenter Study. Ophthalmology.1995 Aug; 102:1129-1138. 137. Holland EJ, Lee RM, Bucci FA, Janda AM, Doughman DJ, Harris JK, Krachmer JH. Mottled cyan opacification of the posterior cornea in contact lens wearers. Am J Ophthalmol. 1995 May; 119:620-626. 138. Murali S, Hardten DR, DeMartelaere S, Olevsky OM, Mindrup EA, Hecht ML, Karlstad R, Chan CC, Holland EJ. Effect of topically administered platelet-derived growth factor on corneal wound strength. Current Eye Research. 1994 Dec; 13(12):857-862. 139. Olsen TW, Benegas NM, Joplin AC, Evangelista TE, Mindrup EA, Holland EJ. Rapamycin inhibits corneal allograft rejection and neovascularization. Arch Ophthalmol. 1994 Nov; 112(11):1471-1475. 140. Grimmett MR, Holland EJ, Krachmer JH. Therapeutic keratoplasty after radial keratotomy. Am J Ophthalmol. 1994 Jul; 118(1):108-109. 141. Holland EJ, Olsen TW, Chan CC, Bergstrom L, Palestine AG, Nussenblatt RB. Kinetics of corneal transplant rejection in the rat penetrating keratoplasty model. Cornea. 1994 July; 13(4):317-323. 142. Lane SS, Mizener MW, Dubbel PA, Mindrup EA, Wick AA, Doughman DJ, Holland EJ. Whole globe enucleation versus in situ corneal excision: A study of tissue trauma and contamination. Cornea. 1994 July; 13(4):305-309. 143. Kodsi SR, Bloom KE, Egbert JE, Holland EJ, Cameron JD. Ocular and Systemic Manifestations of Encephalocraniocutaneous Iipomatosis. AM J Ophthalmol. 1994 Jul; 118(1):77-82. 144. Summers CG, Whitley CB, Holland EJ, Purple RL, Krivit W. Dense peripheral corneal clouding in scheie syndrome. Cornea. 1994 May; 13(3):277-279. 145. Olsen TW, Hardten DR, Meiusi RS, Holland EJ. Linear endotheliitis. Am J Ophthalmol. 1994 Apr; 117:468-474. 146. Holland EJ, Olsen TW, Sterrer J, Ketchum J, Mindrup EA, Gruber SA. Suppression of graft rejection using 15-deoxyspergualin in the allogeneic rat penetrating keratoplasty model. Cornea. 1994 Jan; 13(1):28-32. 147. Stone EM, Mathers WD, Rosenwasser GOD, Holland EJ, Folberg R, Krachmer JH, Nichols BE, Gorevic PD, Taylor CM, Streb LM, Fishbaugh JA, Daley TE, Sucheski BM, Sheffield VC. Three autosomal dominant corneal dystrophies map to chromosome 5q. Nature Genetics. 1994 Jan; 6(1):47-51. 148. Wilhelmus KR, Stulting RD, Sugar J, Khan MM, Holland EJ. Primary corneal graft failure - A National Reporting System. Arch Ophthalmol. 1995; 113:1497. 149. Waring GO, Lynn MJ, MCDonnel PJ (Holland EJ part of PERK Study Group). Results of the prospective evaluation of radial keratotomy study 10 years after surgery. Arch Ophthalmol. 1994; 112:1298-1306. 150. Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, Lam S, Tessler HH, Sugar J. Topical cyclosporin a in the treatment of anterior segment inflammatory disease. Cornea. 1993 Sep; 12(5):413-419. 151. Hardten DR, Holland EJ, Doughman DJ, Nelson JD, Evangelista AW, Ketcham JM. Clinical and anatomical study of the effect of transscleral fixation of posterior chamber lenses on early postkeratoplasty astigmatism. Cornea. 1993 Jul; 12(4):282-288. 152. Gothard TW, Hardten DR, Lane SS, Doughman DJ, Krachmer JH, Holland EJ. Clinical findings in Brown-McLean Syndrome. Am J Ophthalmol. 1993 Jun; 115(6):729-737. 153. Florine CW, Dwyer M, Holland EJ. Wegener's granulomatosis presenting with sclerokeratitis diagnosed by antineutrophil cytoplasmic autoantibodies (ANCA). Survey of Ophthalmology.1993 Mar-Apr; 37:373-376. 154. Hardten DR, Brown DJ, Holland EJ. Results of Neodymium: YAG laser transscleral cyclophotocoagulation for postkeratoplasty glaucoma. Journal of Glaucoma. 1993; 2(4):241-245. 155. Holland EJ, Mahanti RL, Belongia EA, Mizener MW, Goodman JL, Andres CW, Osterholm MT: Ocular involvement in an outbreak of herpes gladiatorum. Am. J. Ophthalmol. 1992 Dec; 114(6):680-684. 156. Lane SS, Lubniewski AJ, Holland EJ. Transsclerally sutured posterior chamber lenses: improved lens designs and techniques to maximize lens stability and minimize suture erosion. Semin Ophthalmol. 1992 Dec; 7(4):245-252. 157. Obritsch WF, Kawashima H, Evangelista A, Ketcham JM, Holland EJ, Gregerson DS. Inhibition of in Vitro T cell activation by corneal endothelial cells. Cellular Immunology. 1992 Oct; 144:80-94. 158. Holland EJ, Daya SM, Stone EM, Folberg R, Dobler AA, Cameron JD, Doughman DJ. Avellino corneal dystrophy: Clinical manifestations and natural history. Ophthalmology. 1992 Oct; 99(10):1564-1568. 159. Holland EJ, Daya SM, Evangelista A, Ketcham JM, Lubniewski AJ, Doughman DJ. Penetrating keratoplasty and transscleral fixation of posterior chamber lens. Am J. Ophthalmol. 1992 Aug; 114:182-187. 160. Hardten DR, Doughman DJ, Holland EJ, and Gothard TW: Persistent superficial punctuate keratitis after resolution of chlamydial follicular conjunctivitis. Cornea.1992 Jul; 11(4):360363. 161. Hardten DR, Holland EJ, Doughman DJ, and Nelson JD: Early post keratoplasty astigmatism following placement of anterior chamber lenses and transsclerally sutured posterior chamber lenses. CLAO. 1992 Apr; 18(2):108-111. 162. Dusenbery KE, Alul IH, Holland EJ, Faiz MK, Levitt SH: Beta irradiation of recurrent pterygia: results and complications. Int. J. Rad. Biol and Physics. 1992; 24(2):315320. 163. Smith SG, Holland EJ, Pederson JE. Peripheral anterior synechiae formation with anterior chamber intraocular lenses. Ophthalmic Surgery. 1992; 23: 316-319. 164. Holland EJ, Alul IH, Meisler DM, Epstein RJ, Rotkis WM, Nathenson AL, Liesegang TJ. Subepithelial infiltrates in acanthamoeba keratitis. Am J. Ophthalmol. 1991Oct; 112(4): 414-418. 165. Belongia EA, Goodman JL, Holland EJ, Andres CW, Homann SR, Mahanti RL, Mizener MW, Erice A, Osterholm MT. An outbreak of herpes gladiatorum at a high school wrestling camp. N. Engl. J. Med. 1991 Sep; 325(13):906-910. 166. Holland EJ, Chan CC, Wetzig RP, Palestine AG, Nussenblatt RB. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea. 1991Sep; 10(5):374-380. 167. Bucci FA, Holland EJ, Lindstrom RL. Corneal autografts for external knots in transsclerally sutured posterior chamber lenses. Am. J. Ophthalmol.1991 Sept; 112(3): 353-354. 168. Rubin BI, Holland EJ, de Smet, MD, Belfort R, Nussenblatt RB. Response of reactivated ligneous conjunctivitis to topical cyclosporine. Am J. Ophthalmol. 1991 July; 112(1):95-96. 169. Summers CG, Holland EJ. Neodymium-YAG pupilloplasty in pediatric aphakia. Journal of Pediatric Ophthalmology and Strabismus. 1991 May-Jun; 28(3):155-156. 170. Tchah H, Youn DH and Holland EJ. Experimental orthotopic penetrating keratoplasty- a rat penetrating keratoplasty model. J Korean Med Sci. 1991 Mar; 6(1):15-19 171. Bucci FA, Jr., Holland EJ. Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole. Am. J. Ophthalmol. 1991; 111:116-118. 172. Meiusi RS, Cameron JD, Holland EJ and Summers CG. Discoid lupus erythematosus of the eyelid complicated by wound dehiscence. Am. J. Ophthalmol. 1991; 111:108-109. 173. Lubniewski AJ, Holland EJ, Van Meter WS, Gussler D, Parelman J, Smith ME. Histological study of eyes with transsclerally sutured posterior chamber intraocular lenses. Am. J. Ophthalmol. 1990; 110: 237- 243. 174. Lubniewski AJ, Houchin KW, Holland EJ, Weeks DA, Wessels IF, McNeill J, Cameron JD. Posterior infectious crystalline keratopathy with staphylococcus epidermidis. Ophthalmol. 1990; 97:1454-1459. 175. Goodman JL, Holland EJ, Andres CW, Homann SR, Mahanti RL, Mizener MW, Erice A. Herpes gladiatorum at a high school wrestling camp-Minnesota. MMWR. 1990; 39:69-71. 176. Duffey RJ, Holland EJ, Agapitos PJ and Lindstrom RL. Anatomical study of transsclerally sutured intraocular lens implantation. Am. J. Ophthalmol. 1989; 108:300-309. 177. Holland EJ, Chan CC, Palestine AG, Rowsey JJ, Nussenblatt RB. Systemic levels of cyclosporine a following long-term topical application. (Correspondence) Am. J. Ophthalmol. 1989.108:211-212. 178. Zabel RW, Winegarden T, Holland EJ, Doughman DJ. Acinetobacter corneal ulcer following penetrating keratoplasty. Am. J. Ophthalmol. 1989;107:677-678. 179. Parsons MR, Holland EJ and Agapitos PJ. Nocardia asteroides keratitis associated with extended soft contact lens wear. Canad. J. Ophthalmol. 1989; 24:120-122. 180. Holland EJ, Chan CC, Kuwabara T, Palestine AG, Rowsey JJ, Nussenblatt RB. Immunohistologic findings and treatment with cyclosporine in ligneous conjunctivitis. Am. J. Ophthalmol. 1989;107:160-166. 181. Pearlstein ES, Agapitos PJ, Cantrill HL, Holland EJ, Williams P, Lindstrom RL. Ruptured globe after radial keratotomy. Am. J. Ophthalmol. 1988 Dec; 106(6):755-757. 182. Holland EJ, Stein CA, Palestine AG, LaRocca R, Chan C, Kuwabara T, Myers CE, Thomas R, McAtee N, Nussenblatt RN. Suramin keratopathy. Am. J. Ophthalmol. 1988 Aug;106(2): 216-220. 183. Holland EJ, Bennett SR, Brannian R, Osborne JC, Goeken JA, and Krachmer JH. The Risk of Cytomegalovirus Transmission by Penetrating Keratoplasty. Am. J. Ophthalmol. 1988 Apr; V-105 N-4: 357-360. 184. Holland EJ, Bennett SR, Brannian R, Osborne JC, Goeken JA, and Krachmer JH. CMV and penetrating keratoplasty (Correspondence). Am. J. Ophthalmol. 1988;106:239-240. 185. Mannis MJ, Zadnik K, Morrison T, Holland EJ and Krachmer JH. Personality trends in keratoconus. An Analysis. Arch. Ophthalmol. 1987 Jun; 105(6):798-800. 186. Willis RM, Folberg R, Krachmer JH and Holland EJ. The treatment of aqueous-deficient dry eye with removable punctal plugs. A Clinical and Impression-cytologic Study. Ophthalmol. 1987 May; 94(5):514-518. 187. Thorgaard GL, Holland EJ and Krachmer JH. Corneal edema induced by cold in trigeminal nerve palsy. Am. J. Ophthalmol. 1987 May; 103(5):641-646. 188. Holland EJ, DeRuyter DN and Doughman DJ. Langerhans cells in organ-cultured corneas. Arch. Ophthalmol. 1987 Apr; 105(4):542-545. 189. Holland EJ, Chan CC, Wetzig RP, Nussenblatt RB. Penetrating keratoplasty in the rat. The National Eye Institute Annual Report. 1987:243-244. 190. Holland EJ, Loren AB, O'Donnell MJ, Spencer DJ, Tessler HH and Yokoyama MM. HLAB27, Klebsiella Pneumonia, and the relation to acute anterior uveitis. Invest Ophthalmol. 1982 Feb; 22: 213-219. 191. Holland EJ, Loren AB, Scott PJ, Niwa Y and Yokoyama MM. Demonstration of neutrophil dysfunction in the serum of patients with cystic fibrosis. J. Clin. Lab. Immunol. 1981 Sep; 6(2):137-139.
Related documents